In Re: Purdue Pharma L.P.
This text of In Re: Purdue Pharma L.P. (In Re: Purdue Pharma L.P.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
22-110-bk (L) In re: Purdue Pharma L.P.
1 In the 2 United States Court of Appeals 3 For the Second Circuit 4 _____________________________________
5 AUGUST TERM 2021 6 7 ARGUED: APRIL 29, 2022 8 DECIDED: MAY 30, 2023 9 10 NOS. 22-110-bk (L), 22-113-bk, 22-115-bk, 22-116-bk, 22-117-bk, 22-119-bk, 11 22-121-bk, 22-299-bk, 22-203-bk 12 _____________________________________
13 In Re: Purdue Pharma L.P., Purdue Pharma Inc, Purdue Transdermal 14 Technologies L.P., Purdue Pharma Manufacturing L.P., Purdue Pharmaceuticals 15 L.P., Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield 16 BioVentures L.P., Seven Seas Hill Corp., Ophir Green Corp., Purdue Pharma of 17 Puerto Rico, Avrio Health L.P., Purdue Pharmaceutical Products L.P., Purdue 18 Neuroscience Company, Nayatt Cove Lifescience Inc., Button Land L.P., Rhodes 19 Associates L.P., Paul Land Inc., Quidnick Land L.P., Rhodes Pharmaceuticals 20 L.P., Rhodes Technologies, UDF LP, SVC Pharma LP, SVC Pharma Inc., 21 22 Debtors. 23 ************************************* 24 25 PURDUE PHARMA, L. P., PURDUE PHARMA INC, PURDUE TRANSDERMAL 26 TECHNOLOGIES L.P., PURDUE PHARMA MANUFACTURING L.P., PURDUE 27 PHARMACEUTICALS L.P., IMBRIUM THERAPEUTICS L.P., ADLON THERAPEUTICS L.P., 28 GREENFIELD BIOVENTURES L.P., SEVEN SEAS HILL CORP., OPHIR GREEN CORP., 29 PURDUE PHARMA OF PUERTO RICO, AVRIO HEALTH L.P., PURDUE PHARMACEUTICAL 30 PRODUCTS L.P., PURDUE NEUROSCIENCE COMPANY, NAYATT COVE LIFESCIENCE
1 1 INC., BUTTON LAND L.P., RHODES ASSOCIATES L.P., PAUL LAND INC., QUIDNICK 2 LAND L.P., RHODES PHARMACEUTICALS L.P., RHODES TECHNOLOGIES, UDF LP, 3 SVC PHARMA LP, SVC PHARMA INC., 4 5 Debtors-Appellants-Cross-Appellees, 6 7 THE OFFICIAL COMMITTEE OF UNSECURED CREDITORS OF PURDUE PHARMA L.P., ET 8 AL., AD HOC COMMITTEE OF GOVERNMENTAL AND OTHER CONTINGENT LITIGATION 9 CLAIMANTS, THE RAYMOND SACKLER FAMILY, AD HOC GROUP OF INDIVIDUAL 10 VICTIMS OF PURDUE PHARMA, L.P., MULTI-STATE GOVERNMENTAL ENTITIES GROUP, 11 MORTIMER-SIDE INITIAL COVERED SACKLER PERSONS, 12 13 Appellants-Cross-Appellees, 14 15 — v. — 16 17 THE CITY OF GRANDE PRAIRIE, AS REPRESENTATIVE PLAINTIFF FOR A CLASS 18 CONSISTING OF ALL CANADIAN MUNICIPALITIES, THE CITIES OF BRANTFORD, GRAND 19 PRAIRIE, LETHBRIDGE, AND WETASKIWIN, THE PETER BALLANTYNE CREE NATION, 20 ON BEHALF OF ALL CANADIAN FIRST NATIONS AND METIS PEOPLE, THE PETER 21 BALLANTYNE CREE NATION ON BEHALF ITSELF, AND THE LAC LA RONGE INDIAN 22 BAND, 23 24 Appellees-Cross Appellants, 25 26 THE STATE OF WASHINGTON, STATE OF MARYLAND, DISTRICT OF COLUMBIA, U.S. 27 TRUSTEE WILLIAM K. HARRINGTON, STATE OF CONNECTICUT, RONALD BASS, STATE 28 OF CALIFORNIA, PEOPLE OF THE STATE OF CALIFORNIA, BY AND THROUGH ATTORNEY 29 GENERAL ROB BONTA, STATE OF OREGON, STATE OF DELAWARE, BY AND THROUGH 30 ATTORNEY GENERAL JENNINGS, STATE OF RHODE ISLAND, STATE OF VERMONT, 31 ELLEN ISAACS, ON BEHALF OF PATRICK RYAN WROBLEWSKI, MARIA ECKE, ANDREW 32 ECKE, RICHARD ECKE, 33 34 Appellees. 35 _____________________________________
36 2 1 Before: NEWMAN, WESLEY, and LEE, Circuit Judges.
2 ________ 3 4 Appellants appeal from an order of the United States District Court for the 5 Southern District of New York (Colleen McMahon, J.) reversing an order of the 6 United States Bankruptcy Court for the Southern District of New York (Robert D. 7 Drain, Bankr. J.) confirming a Chapter 11 plan that included nonconsensual third- 8 party releases of direct claims against non-debtors. We hold that nonconsensual 9 third-party releases of such direct claims are statutorily permitted under 11 U.S.C. 10 §§ 105(a) and 1123(b)(6) of the Bankruptcy Code. We further conclude that this 11 Court’s case law also allows for nonconsensual third-party claim releases in 12 specific circumstances, such as those presented in this appeal. Accordingly, we 13 REVERSE the district court’s order holding that the Bankruptcy Code does not 14 permit nonconsensual third-party releases against non-debtors, AFFIRM the 15 bankruptcy court’s approval of the Plan, and REMAND the case to the district 16 court for such further proceedings as may be required, consistent with this 17 opinion. We also AFFIRM the district court’s denial of the Canadian Creditors’ 18 cross-appeal.
19 Judge Wesley concurs in the judgment in a separate opinion.
20 ________ 21 22 MARSHALL S. HUEBNER, (Benjamin S. 23 Kaminetzky, Eli J. Vonnegut, James I. 24 McClammy, Marc J. Tobak, 25 Christopher S. Robertson, Gerard X. 26 McCarthy, and Garrett L. Cardillo, on 27 the brief), Davis Polk & Wardwell LLP, 28 New York, New York; Gregory G. 29 Garre, Charles S. Dameron, Eric J. 30 Konopka, and Joshua J. Craddock, 31 Latham & Watkins LLP, Washington, 32 D.C. (on the brief), for Debtors- 33 Appellants-Cross-Appellees Purdue 34 Pharma L.P., Purdue Pharma Inc.,
3 1 Purdue Transdermal Technologies L.P., 2 Purdue Pharma Manufacturing L.P., 3 Purdue Pharmaceuticals L.P., Imbrium 4 Therapeutics L.P., Adlon Therapeutics 5 L.P., Greenfield BioVentures L.P., Seven 6 Seas Hill Corp., Ophir Green Corp., 7 Purdue Pharma of Puerto Rico, Avrio 8 Health L.P., Purdue Pharmaceutical 9 Products L.P., Purdue Neuroscience 10 Company, Nayatt Cove Lifescience Inc., 11 Button Land L.P., Rhodes Associates 12 L.P., Paul Land Inc., Quidnick Land L.P., 13 Rhodes Pharmaceuticals L.P., Rhodes 14 Technologies, UDF LP, SVC Pharma LP, 15 and SVC Pharma Inc. 16 17 MITCHELL P. HURLEY (Erik Y. Preis 18 and Sara L. Brauner, on the brief), Akin 19 Gump Strauss Hauer & Feld LLP, 20 New York, New York; Z.W. Julius 21 Chen, Akin Gump Strauss Hauer & 22 Feld LLP, Washington, D.C. (on the 23 brief), for Appellant-Cross-Appellee The 24 Official Committee of Unsecured 25 Creditors of Purdue Pharma L.P., et al. 26 27 ROY T. ENGLERT, JR., (Lawrence S. 28 Robbins, on the brief), Robbins, 29 Russell, Englert, Orseck & Untereiner 30 LLP, Washington, D.C.; Kenneth H. 31 Eckstein, Rachael Ringer, and David 32 E. Blabey Jr., Kramer Levin Naftalis & 33 Frankel LLP, New York, New York 34 (on the brief); David J. Molton, Brown 35 Rudnick LLP, New York, New York 36 (on the brief); Richard J. Leveridge,
4 1 Richard D. Shore, and Daniel I. Wolf, 2 Gilbert LLP, Washington, D.C. (on the 3 brief); Melanie L. Cyganowski, 4 Otterbourg P.C., New York, New 5 York (on the brief), for Appellant-Cross- 6 Appellee Ad Hoc Committee of 7 Governmental & Other Contingent 8 Litigation Claimants. 9 10 J. CHRISTOPHER SHORE (Michele J. 11 Meises and Alice Tsier, on the brief), 12 White & Case LLP, New York, New 13 York; Edward E. Neiger, ASK LLP, 14 New York, New York (on the brief), for 15 Appellant-Cross-Appellee Ad Hoc Group 16 of Individual Victims of Purdue Pharma, 17 L.P. 18 19 JEFFREY A. LIESEMER (Kevin C. 20 Maclay, Todd E. Phillips, and Lucas 21 H. Self, on the brief), Caplin & 22 Drysdale, Chartered, Washington, 23 D.C., for Appellant-Cross-Appellee 24 Multi-State Governmental Entities 25 Group. 26 27 MAURA KATHLEEN MONAGHAN 28 (Jasmine Ball, on the brief), Debevoise 29 & Plimpton LLP, New York, New 30 York, for Appellant-Cross-Appellee 31 Mortimer-Side Initial Covered Sackler 32 Persons. 33 34 Gregory P. Joseph, Mara Leventhal, 35 Joseph Hage Aaronson LLC, New 36 York, New York; Gerard Uzzi,
5 1 Alexander B. Lees, Milbank LLP, New 2 York, New York, for Appellant-Cross- 3 Appellee The Raymond Sackler Family. 4 5 J. CARL CECERE, Cecere PC, Dallas, 6 Texas; Allen J.
Free access — add to your briefcase to read the full text and ask questions with AI
22-110-bk (L) In re: Purdue Pharma L.P.
1 In the 2 United States Court of Appeals 3 For the Second Circuit 4 _____________________________________
5 AUGUST TERM 2021 6 7 ARGUED: APRIL 29, 2022 8 DECIDED: MAY 30, 2023 9 10 NOS. 22-110-bk (L), 22-113-bk, 22-115-bk, 22-116-bk, 22-117-bk, 22-119-bk, 11 22-121-bk, 22-299-bk, 22-203-bk 12 _____________________________________
13 In Re: Purdue Pharma L.P., Purdue Pharma Inc, Purdue Transdermal 14 Technologies L.P., Purdue Pharma Manufacturing L.P., Purdue Pharmaceuticals 15 L.P., Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield 16 BioVentures L.P., Seven Seas Hill Corp., Ophir Green Corp., Purdue Pharma of 17 Puerto Rico, Avrio Health L.P., Purdue Pharmaceutical Products L.P., Purdue 18 Neuroscience Company, Nayatt Cove Lifescience Inc., Button Land L.P., Rhodes 19 Associates L.P., Paul Land Inc., Quidnick Land L.P., Rhodes Pharmaceuticals 20 L.P., Rhodes Technologies, UDF LP, SVC Pharma LP, SVC Pharma Inc., 21 22 Debtors. 23 ************************************* 24 25 PURDUE PHARMA, L. P., PURDUE PHARMA INC, PURDUE TRANSDERMAL 26 TECHNOLOGIES L.P., PURDUE PHARMA MANUFACTURING L.P., PURDUE 27 PHARMACEUTICALS L.P., IMBRIUM THERAPEUTICS L.P., ADLON THERAPEUTICS L.P., 28 GREENFIELD BIOVENTURES L.P., SEVEN SEAS HILL CORP., OPHIR GREEN CORP., 29 PURDUE PHARMA OF PUERTO RICO, AVRIO HEALTH L.P., PURDUE PHARMACEUTICAL 30 PRODUCTS L.P., PURDUE NEUROSCIENCE COMPANY, NAYATT COVE LIFESCIENCE
1 1 INC., BUTTON LAND L.P., RHODES ASSOCIATES L.P., PAUL LAND INC., QUIDNICK 2 LAND L.P., RHODES PHARMACEUTICALS L.P., RHODES TECHNOLOGIES, UDF LP, 3 SVC PHARMA LP, SVC PHARMA INC., 4 5 Debtors-Appellants-Cross-Appellees, 6 7 THE OFFICIAL COMMITTEE OF UNSECURED CREDITORS OF PURDUE PHARMA L.P., ET 8 AL., AD HOC COMMITTEE OF GOVERNMENTAL AND OTHER CONTINGENT LITIGATION 9 CLAIMANTS, THE RAYMOND SACKLER FAMILY, AD HOC GROUP OF INDIVIDUAL 10 VICTIMS OF PURDUE PHARMA, L.P., MULTI-STATE GOVERNMENTAL ENTITIES GROUP, 11 MORTIMER-SIDE INITIAL COVERED SACKLER PERSONS, 12 13 Appellants-Cross-Appellees, 14 15 — v. — 16 17 THE CITY OF GRANDE PRAIRIE, AS REPRESENTATIVE PLAINTIFF FOR A CLASS 18 CONSISTING OF ALL CANADIAN MUNICIPALITIES, THE CITIES OF BRANTFORD, GRAND 19 PRAIRIE, LETHBRIDGE, AND WETASKIWIN, THE PETER BALLANTYNE CREE NATION, 20 ON BEHALF OF ALL CANADIAN FIRST NATIONS AND METIS PEOPLE, THE PETER 21 BALLANTYNE CREE NATION ON BEHALF ITSELF, AND THE LAC LA RONGE INDIAN 22 BAND, 23 24 Appellees-Cross Appellants, 25 26 THE STATE OF WASHINGTON, STATE OF MARYLAND, DISTRICT OF COLUMBIA, U.S. 27 TRUSTEE WILLIAM K. HARRINGTON, STATE OF CONNECTICUT, RONALD BASS, STATE 28 OF CALIFORNIA, PEOPLE OF THE STATE OF CALIFORNIA, BY AND THROUGH ATTORNEY 29 GENERAL ROB BONTA, STATE OF OREGON, STATE OF DELAWARE, BY AND THROUGH 30 ATTORNEY GENERAL JENNINGS, STATE OF RHODE ISLAND, STATE OF VERMONT, 31 ELLEN ISAACS, ON BEHALF OF PATRICK RYAN WROBLEWSKI, MARIA ECKE, ANDREW 32 ECKE, RICHARD ECKE, 33 34 Appellees. 35 _____________________________________
36 2 1 Before: NEWMAN, WESLEY, and LEE, Circuit Judges.
2 ________ 3 4 Appellants appeal from an order of the United States District Court for the 5 Southern District of New York (Colleen McMahon, J.) reversing an order of the 6 United States Bankruptcy Court for the Southern District of New York (Robert D. 7 Drain, Bankr. J.) confirming a Chapter 11 plan that included nonconsensual third- 8 party releases of direct claims against non-debtors. We hold that nonconsensual 9 third-party releases of such direct claims are statutorily permitted under 11 U.S.C. 10 §§ 105(a) and 1123(b)(6) of the Bankruptcy Code. We further conclude that this 11 Court’s case law also allows for nonconsensual third-party claim releases in 12 specific circumstances, such as those presented in this appeal. Accordingly, we 13 REVERSE the district court’s order holding that the Bankruptcy Code does not 14 permit nonconsensual third-party releases against non-debtors, AFFIRM the 15 bankruptcy court’s approval of the Plan, and REMAND the case to the district 16 court for such further proceedings as may be required, consistent with this 17 opinion. We also AFFIRM the district court’s denial of the Canadian Creditors’ 18 cross-appeal.
19 Judge Wesley concurs in the judgment in a separate opinion.
20 ________ 21 22 MARSHALL S. HUEBNER, (Benjamin S. 23 Kaminetzky, Eli J. Vonnegut, James I. 24 McClammy, Marc J. Tobak, 25 Christopher S. Robertson, Gerard X. 26 McCarthy, and Garrett L. Cardillo, on 27 the brief), Davis Polk & Wardwell LLP, 28 New York, New York; Gregory G. 29 Garre, Charles S. Dameron, Eric J. 30 Konopka, and Joshua J. Craddock, 31 Latham & Watkins LLP, Washington, 32 D.C. (on the brief), for Debtors- 33 Appellants-Cross-Appellees Purdue 34 Pharma L.P., Purdue Pharma Inc.,
3 1 Purdue Transdermal Technologies L.P., 2 Purdue Pharma Manufacturing L.P., 3 Purdue Pharmaceuticals L.P., Imbrium 4 Therapeutics L.P., Adlon Therapeutics 5 L.P., Greenfield BioVentures L.P., Seven 6 Seas Hill Corp., Ophir Green Corp., 7 Purdue Pharma of Puerto Rico, Avrio 8 Health L.P., Purdue Pharmaceutical 9 Products L.P., Purdue Neuroscience 10 Company, Nayatt Cove Lifescience Inc., 11 Button Land L.P., Rhodes Associates 12 L.P., Paul Land Inc., Quidnick Land L.P., 13 Rhodes Pharmaceuticals L.P., Rhodes 14 Technologies, UDF LP, SVC Pharma LP, 15 and SVC Pharma Inc. 16 17 MITCHELL P. HURLEY (Erik Y. Preis 18 and Sara L. Brauner, on the brief), Akin 19 Gump Strauss Hauer & Feld LLP, 20 New York, New York; Z.W. Julius 21 Chen, Akin Gump Strauss Hauer & 22 Feld LLP, Washington, D.C. (on the 23 brief), for Appellant-Cross-Appellee The 24 Official Committee of Unsecured 25 Creditors of Purdue Pharma L.P., et al. 26 27 ROY T. ENGLERT, JR., (Lawrence S. 28 Robbins, on the brief), Robbins, 29 Russell, Englert, Orseck & Untereiner 30 LLP, Washington, D.C.; Kenneth H. 31 Eckstein, Rachael Ringer, and David 32 E. Blabey Jr., Kramer Levin Naftalis & 33 Frankel LLP, New York, New York 34 (on the brief); David J. Molton, Brown 35 Rudnick LLP, New York, New York 36 (on the brief); Richard J. Leveridge,
4 1 Richard D. Shore, and Daniel I. Wolf, 2 Gilbert LLP, Washington, D.C. (on the 3 brief); Melanie L. Cyganowski, 4 Otterbourg P.C., New York, New 5 York (on the brief), for Appellant-Cross- 6 Appellee Ad Hoc Committee of 7 Governmental & Other Contingent 8 Litigation Claimants. 9 10 J. CHRISTOPHER SHORE (Michele J. 11 Meises and Alice Tsier, on the brief), 12 White & Case LLP, New York, New 13 York; Edward E. Neiger, ASK LLP, 14 New York, New York (on the brief), for 15 Appellant-Cross-Appellee Ad Hoc Group 16 of Individual Victims of Purdue Pharma, 17 L.P. 18 19 JEFFREY A. LIESEMER (Kevin C. 20 Maclay, Todd E. Phillips, and Lucas 21 H. Self, on the brief), Caplin & 22 Drysdale, Chartered, Washington, 23 D.C., for Appellant-Cross-Appellee 24 Multi-State Governmental Entities 25 Group. 26 27 MAURA KATHLEEN MONAGHAN 28 (Jasmine Ball, on the brief), Debevoise 29 & Plimpton LLP, New York, New 30 York, for Appellant-Cross-Appellee 31 Mortimer-Side Initial Covered Sackler 32 Persons. 33 34 Gregory P. Joseph, Mara Leventhal, 35 Joseph Hage Aaronson LLC, New 36 York, New York; Gerard Uzzi,
5 1 Alexander B. Lees, Milbank LLP, New 2 York, New York, for Appellant-Cross- 3 Appellee The Raymond Sackler Family. 4 5 J. CARL CECERE, Cecere PC, Dallas, 6 Texas; Allen J. Underwood, II, Lite 7 Depalma Greenberg & Afanador, 8 LLC, Newark, New Jersey (on the 9 brief), for Appellees-Cross-Appellants 10 The City of Grand Prairie, as 11 Representative Plaintiff for a Class 12 Consisting of All Canadian 13 Municipalities, The Cities of Brantford, 14 Grand Prairie, Lethbridge, and 15 Wetaskiwin, The Peter Ballantyne Cree 16 Nation, on behalf of All Canadian First 17 Nations and Metis People, the Peter 18 Ballantyne Cree Nation, on behalf of 19 itself, and the Lac La Ronge Indian Band. 20 21 MICHAEL SHIH, Attorney, Appellate 22 Staff Civil Division, (Michael S. Raab 23 and Sean R. Janda, Attorneys, 24 Appellate Staff Civil Division, on the 25 brief), for Sarah E. Harrington, Deputy 26 Assistant Attorney General, (Beth A. 27 Levene and Sumi K. Sakata, Trial 28 Attorneys, for P. Matthew Sutko, 29 Associate General Counsel, for 30 Ramona D. Elliot, Deputy 31 Director/General Counsel, Executive 32 Office for United States Trustees, on 33 the brief), United States Department of 34 Justice, Washington, D.C.; Lawrence 35 H. Fogelman, Peter Aronoff, Danielle 36 J. Levine, Assistant United States
6 1 Attorneys, for Damian Williams, 2 United States Attorney for the 3 Southern District of New York, New 4 York, New York (on the brief), for 5 Appellee U.S. Trustee William K. 6 Harrington. 7 8 Ronald Bass, pro se, North Plainfield, 9 New Jersey. 10 11 Ellen Isaacs, pro se, on behalf of 12 Patrick Ryan Wroblewski, and all 13 similarly situated persons, Floyd, 14 Virginia. 15 16 Maria Ecke, Andrew Ecke, Richard 17 Ecke, pro se, West Simsbury, 18 Connecticut. 19 20 Gregg M. Galardi, Ropes & Gray LLP, 21 New York, New York; Douglas 22 Hallward-Driemeier, Ropes & Gray 23 LLP, Washington, D.C.; Andrew G. 24 Devore, Ropes & Gray LLP, Boston, 25 Massachusetts; Ryan Preston Dahl, 26 Ropes & Gray LLP, Chicago, Illinois, 27 for Amici Curiae Law Professors in 28 support of Appellants. 29 30 Paul H. Zumbro, George E. Zobitz, 31 Lauren A. Moskowitz, Cravath, 32 Swaine & Moore LLP, New York, 33 New York, for Amicus Curiae The 34 Association of the Bar of the City of New 35 York. 36
7 1 Tara S. Morrissey, U.S. Chamber 2 Litigation Center, Washington, D.C., 3 for the Chamber of Commerce of the 4 United States of America; David H. 5 Thompson, Brian W. Barnes, John W. 6 Tienken, Cooper & Kirk, PLLC, 7 Washington, D.C., for Amici Curiae the 8 Chamber of Commerce of the United 9 States of America, the American Tort 10 Reform Association, and Product 11 Liability Advisory Council, Inc. 12 13 Andrew K. Glenn, Jed I. Bergman, 14 Shai Schmidt, Glenn Agre Bergman & 15 Fuentes LLP, New York, New York, 16 for Amici Curiae Bankruptcy Law 17 Professors Ralph Brubaker, George W. 18 Kuney, and Bruce A. Markell. 19 20 Joshua L. Seifert, Joshua. L. Seifert 21 PLLC, New York, New York, for Amici 22 Curiae Law Professors in Support of 23 Appellees Regarding the “Abuse” 24 Standard. 25 26 Robert J. Keach, Bernstein Shur 27 Sawyer & Nelson, P.A., Portland, 28 Maine; Albert Togut, Togut, Segal & 29 Segal LLP, New York, New York, for 30 Amici Curiae Commissioners of the 31 American Bankruptcy Institute’s 32 Commission to Study the Reform of 33 Chapter 11. 34
8 1 Daniel R. Walfish, Walfish & Fissell 2 PLLC, for Amicus Curiae Professor 3 Adam J. Levitin. 4 5 Harold D. Israel, Levenfeld 6 Pearlstein, LLC, Chicago, Illinois; 7 Scott R. Bickford, Martzell, Bickford 8 & Centola, New Orleans, Louisiana, 9 for Amicus Curiae the Ad Hoc 10 Committee of NAS Children. 11 12 _____________________________________ 13 14 15 EUNICE C. LEE, Circuit Judge:
16 Bankruptcy is inherently a creature of competing interests, compromises,
17 and less-than-perfect outcomes. Because of these defining characteristics, total
18 satisfaction of all that is owed—whether in money or in justice—rarely occurs.
19 When a bankruptcy is the result of mass tort litigation against the debtor, the
20 complexities are magnified because the debts owed are wide-ranging and the
21 harm caused goes beyond the financial. That is the circumstance here.
22 The Debtor, Purdue Pharma L.P. (“Purdue”), was owned and operated by
23 the Sackler family 1 for decades. In the 1990s, Purdue introduced to market—and
1 The district court explained that the “Sackler Family,” as used in the court’s opinion, “means the Mortimer D. Sackler Family (also known as ‘Side A’ of the Sackler family) and the Raymond R. Sackler Family (also known as ‘Side B’ of the Sackler family.).” In re Purdue Pharma, L.P., 635 B.R. 26, 35 n.2 (S.D.N.Y. 2021). The Mortimer D. Sackler family 9 1 promoted as non-addictive—OxyContin, a controlled-release semisynthethic
2 opioid analgesic. In the years following, OxyContin has been blamed for
3 significantly contributing to one of the largest public health crises in this nation’s
4 history: the opioid epidemic.
5 The fallout from this crisis led to a veritable deluge of litigation against both
6 Purdue and individual members of the Sackler family. Claimants, spread across
7 the United States and Canada, included many sufferers of opioid addiction and
8 the families of those lost to opioid overdoses. To settle the mass of civil claims, the
9 parties, including Purdue and the Sacklers, agreed that in exchange for Purdue
10 filing for bankruptcy, the Sacklers would personally contribute billions of dollars
11 to the bankruptcy if all civil claims against them were released. 2
explains that the “Mortimer-side Initial Covered Sackler Persons include Theresa Sackler, Ilene Sackler Lefcourt, Kathe Sackler, and Mortimer D.A. Sackler, as well as trusts of which they are beneficiaries and the trustees of those trusts, and Beacon Company.” Br. for Appellant-Cross-Appellee Mortimer-Side Initial Covered Sackler Persons at 1 n.1. The Raymond R. Sackler family explains that the “Raymond Sackler family is comprised of natural persons who are descendants of Raymond R. Sackler and current and former spouses of their descendants.” Br. for Appellant-Cross-Appellee the Raymond Sackler Family at 1 n.1. 2 The district court explained that the Sacklers’ contribution would go “to a fund that
would be used to resolve both public and private civil claims as well as both civil and criminal settlements with the federal government.” In re Purdue Pharma, L.P., 635 B.R. at 70. 10 1 In accordance with that plan, Purdue and its related entities (together, the
2 “Debtors” or “Purdue”) filed for bankruptcy; the Sacklers did not. Following an
3 intensive months-long and multi-phase mediation involving various interested
4 parties and potential creditors of Purdue, the bankruptcy court approved the
5 proposed bankruptcy plan. In doing so, the court limited the release of claims
6 against the Sacklers to only claims that directly affected the Debtors’ estate and for
7 which Purdue’s conduct was a legal cause, or a legally relevant factor, of any
8 released cause of action against the Sacklers. In exchange, the Sacklers agreed to
9 contribute a total $5.5-6.0 billion to the bankruptcy. On subsequent appeal,
10 however, the district court for the Southern District of New York reversed the
11 bankruptcy court and vacated the court’s confirmation order, ruling that the
12 Bankruptcy Code did not permit such releases.
13 This appeal followed. During the pendency of the appeal, the various
14 parties to the mediation engaged in further negotiations, resulting in additional
15 changes to the proposed bankruptcy plan. These changes resulted in several more
16 parties dropping their opposition and supporting the further-revised bankruptcy
17 plan. The Appellants, who are challenging the district court’s rejection of the
18 proposed plan, include the Debtors, various creditor and claimant groups, and
11 1 certain Sackler family members. The Appellees are those parties opposed to the
2 proposed plan, although, as noted, their number has dropped since the initial
3 filing of this appeal. These remaining Appellees consist of the U.S. Trustee, several
4 Canadian municipalities and indigenous nations, and several individual pro se
5 plaintiffs.
6 Aside from their legal arguments, the parties contend that various policy
7 considerations should inform whether a bankruptcy plan containing
8 nonconsensual third-party releases of direct claims may be approved. They also
9 raise questions about fairness and accountability, particularly as it relates to the
10 Sacklers, in releasing parties from liability for actions that cause great societal
11 harm. They debate the very nature of bankruptcy, including the role it is intended
12 to serve and the parties it is intended to benefit.
13 But, our role in this appeal does not require us to answer all of these serious
14 and difficult questions. Instead, we are tasked only with resolving two key
15 questions: First, does the Bankruptcy Code permit nonconsensual third-party
16 releases of direct claims against non-debtors, and, Second, if so, were such releases
17 proper here in light of all equitable considerations and the facts of this case. We
18 answer both in the affirmative.
12 1 We conclude that two sections of the Bankruptcy Code, 11 U.S.C. §§ 105(a),
2 1123(b)(6), jointly provide the statutory basis for the bankruptcy court’s authority
3 to approve a plan that includes nonconsensual releases of third-party claims
4 against non-debtors. In addition, this Court has recognized that in specific
5 circumstances—such as those presented by this appeal—bankruptcy courts are
6 permitted to approve of restructuring plans that include such releases. We
7 accordingly hold that the bankruptcy court’s approval of the releases here is
8 permissible both statutorily and under this Court’s case law. We further hold that
9 the bankruptcy court’s inclusion of the releases is equitable and appropriate under
10 the specific factual circumstances of this case, and we articulate several factors to
11 guide the analysis as to when to allow similar releases in reorganization plans.
12 Accordingly, we REVERSE the district court’s order holding that the
13 Bankruptcy Code does not permit nonconsensual releases of third-party direct
14 claims against non-debtors, AFFIRM the bankruptcy court’s approval of the
15 reorganization plan, and REMAND the case to the district court for such further
13 1 proceedings as may be required, consistent with this opinion. We also AFFIRM
2 the district court’s denial of the Canadian Creditors’ cross-appeal.
3 BACKGROUND
4 I. Factual Background
5 The following discussion is limited to those underlying facts that are
6 necessary for a determination of the issues on appeal. 3
7 A. Purdue and OxyContin
8 The Sackler brothers, including Mortimer and Raymond Sackler, 4
9 purchased Purdue, a privately held pharmaceutical company, in the 1950s.
10 Members of the Sackler family held various director and officer positions
11 throughout the company and, from approximately 1993 to 2018, Purdue’s Board
12 of Directors contained at least six members of the Sackler family. Beyond the
13 board, Sackler family members held other positions of influence in the company.
14 For example, Mortimer and Raymond Sackler served as co-chief executive officers
3 The decisions of the bankruptcy and district courts provide a more detailed recitation of the background facts. See In re Purdue Pharma L.P., 633 B.R. 53 (Bankr. S.D.N.Y. 2021) (“Purdue I”); In re Purdue Pharma, L.P., 635 B.R. 26 (S.D.N.Y. 2021) (“Purdue II”). 4 Arthur Sackler sold any interest in Purdue before the development of OxyContin. He
and his heirs are therefore not involved in this action. 14 1 until their deaths, Richard Sackler served as a president, and Mortimer D.A., Ilene,
2 and Kathe Sackler all served as officers.
3 In 1995, Purdue developed, and the Food and Drug Administration (“FDA”)
4 approved, OxyContin, a controlled-release semisynthetic opioid analgesic. At that
5 time, and for years following, Purdue advertised that the time-release formulation
6 prevented OxyContin from posing a threat of abuse or addiction. OxyContin’s
7 FDA label reflected a purportedly low risk of addiction. From 1996 to 2001,
8 Purdue aggressively marketed OxyContin to patients and doctors while
9 downplaying growing addiction concerns. Over this time-period, both prescribed
10 and illegal use of OxyContin increased across the country.
11 Starting in 2000, state governments began to alert Purdue to the widespread
12 abuse of OxyContin, and, in 2001, the FDA required Purdue to remove from its
13 label that OxyContin had a low risk of addiction. In the years that followed,
14 lawsuits against Purdue—brought by, among others, individuals, state
15 governments, and federal agencies—proliferated across the United States.
16 B. The 2004 Indemnity Agreement
17 At the end of 2004, Purdue’s Board of Directors voted to indemnify, among
18 others, Purdue’s directors and officers against claims made in connection with
19 their service to the company. Bryant C. Dunaway v. Purdue Pharma L.P. (In re Purdue 15 1 Pharma L.P.), No. 19-cv-10941-CM (S.D.N.Y. June 22, 2020), ECF No. 24-2
2 (Appellees’ Suppl. App’x at SA 627–36) (the “Sackler-Purdue Indemnity
3 Agreement” or the “Indemnity Agreement”). As part of its obligations under the
4 agreement, Purdue agreed to:
5 indemnify and hold harmless each Indemnitee from and against any 6 and all expenses (including attorneys’ fees), amounts paid or incurred 7 in satisfaction of or as part of settlements, judgments, fines, penalties, 8 liabilities and similar or related items incurred or suffered or 9 threatened to be incurred or suffered as a result of or in connection 10 with such Indemnitee being made or threatened to be made a party 11 to or participant in any pending, threatened or completed actions, 12 suits or proceedings, whether civil, criminal, administrative, 13 arbitrative or investigative . . . . 14 15 Id. at 628–29. Purdue further agreed to “advance all costs and expenses (including
16 attorneys’ fees and expenses) incurred by the Indemnitee in defending any one or
17 more Proceedings.” Id. at 630.
18 The protections conferred by the Indemnity Agreement were expansive and
19 had no immediate time limit. The agreement ensured that “[t]he Indemnitee’s
20 rights under these provisions shall continue after the Indemnitee has ceased to
21 serve” in his or her official capacity at Purdue, and “shall be binding on and inure
22 to the benefit of successors, assigns, legatees, distributees, heirs, executors,
23 guardians, administrators, estates and other legal representatives.” Id. at 635.
16 1 At the same time, the Indemnity Agreement contained a bad faith carveout.
2 Purdue’s indemnification obligations did not extend to matters where “a final
3 decision by a court . . . establishe[d] that the Indemnitee did not act in good faith.”
4 Id. at 629.
5 C. Sackler Conduct Between 2007 and 2019
6 Starting in 2007, the Sacklers anticipated that the effects of litigation against
7 Purdue would eventually impact them directly. See, e.g., Deferred Joint App’x at
8 5059 (David Sackler emailed Jonathan and Richard Sackler, “We will be sued . . . .
9 [A]sk yourself how long it will take these lawyers to figure out that we might settle
10 with them if they can freeze our assets and threaten us.”). From 2008 to 2016,
11 Purdue distributed a significant proportion of the company’s revenue—an
12 approximated $11 billion in total—to Sackler family trusts and holding companies.
13 This represented an increase in the distribution pattern from years prior and
14 “drained Purdue’s total assets by 75% and Purdue’s ‘solvency cushion’ by 82%”
15 during that same time period. Special App’x at 40. By 2018, Purdue defended the
16 many lawsuits against it from a significantly weakened financial position, and, by
17 2019, all Sacklers had stepped down from Purdue’s Board of Directors.
17 1 D. The DOJ Suit
2 In 2019, the United States Attorneys’ Offices for the Districts of New Jersey
3 and Vermont, and the United States Department of Justice (“DOJ”) brought federal
4 criminal and civil charges against Purdue. The criminal counts alleged that
5 Purdue defrauded the government by inducing healthcare providers to prescribe
6 OxyContin and violated the federal anti-kickback statute. The DOJ also brought
7 civil claims under various federal statutes and common law doctrines (such as
8 mistake, unjust enrichment, fraud, nuisance, and negligent entrustment).
9 In 2020, after filing for bankruptcy, Purdue entered into a plea agreement
10 with the DOJ, the terms of which created future obligations on Purdue. First, in
11 exchange for Purdue pleading guilty to violations of the federal anti-kickback
12 statute, the DOJ agreed it would “not initiate any further criminal charges against
13 Purdue.” Deferred Joint App’x at 4798. Second, regarding its civil liability,
14 Purdue agreed to a forfeiture judgment of $2 billion; the judgment gave the DOJ
15 “superpriority” to collect on the forfeiture judgment in the event of a liquidation
16 of Purdue’s estate. Deferred Joint App’x at 4804. Thus, in any future bankruptcy
17 proceedings, the plea required that Purdue satisfy the DOJ’s $2 billion claim ahead
18 of all other creditors’ claims.
18 1 However, the plea agreement also stipulated that the DOJ would agree to
2 release $1.775 billion of its $2 billion claim so long as a future distribution plan met
3 certain requirements, specifically that an abatement trust for the public benefit
4 would be established and a document repository created. Finally, while the plea
5 agreement released Purdue from any additional civil or administrative monetary
6 claims by the government for the covered conduct, it expressly did not release
7 criminal liability.
8 E. Purdue Files for Bankruptcy
9 On September 15, 2019, Purdue and its related entities 5 declared
10 bankruptcy; the Sacklers did not. The Estate of the Debtors (the “Estate” or the
11 “res”) is estimated at approximately $1.8 billion.
12 Three days after the bankruptcy filing, the Debtors sought an injunction
13 halting all other lawsuits (almost 3,000 actions against Purdue and over 400 actions
14 against the Sacklers concerning liability for OxyContin). On October 11, 2019, the
5Purdue consists of Purdue Pharma L.P., Purdue Pharma Inc., Purdue Transdermal Technologies L.P., Purdue Pharma Manufacturing L.P., Purdue Pharmaceuticals L.P., Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Seven Seas Hill Corp., Ophir Green Corp., Purdue Pharma of Puerto Rico, Avrio Health L.P., Purdue Pharmaceutical Products L.P., Purdue Neuroscience Company, Nayatt Cove Lifescience Inc., Button Land L.P., Rhodes Associates L.P., Paul Land Inc., Quidnick Land L.P., Rhodes Pharmaceuticals L.P., Rhodes Technologies, UDF L.P., SVC Pharma L.P., and SVC Pharma Inc. 19 1 bankruptcy court enjoined all litigation. At the time, claims against the Debtors
2 and Sacklers were estimated at more than $40 trillion.
3 II. Procedural History
4 A. The Mediation and Confirmation Process
5 Following discovery, as is typical in Chapter 11 bankruptcy, the bankruptcy
6 court ordered mediation to reach a plan of reorganization and avoid liquidation
7 of the Estate. In addition to Purdue and the Sacklers, there were a number of
8 groups that participated in the mediation. 6
9 The first phase of the mediation addressed the allocation of the Estate’s
10 available funds to non-federal public claimants, such as states and political
11 subdivisions, and private claimants. The second phase largely focused on
12 determining what the Sacklers would contribute to the Debtors’ estate. While this
13 second phase resulted in an agreement in principle among the Sacklers, the
6 The Debtors, Official Committee of Unsecured Creditors of Purdue Pharma L.P., et al. (the “UCC”), Ad Hoc Committee of Governmental and Other Contingent Litigation Claimants (“AHC”), Ad Hoc Group of Non-Consenting States (“NCSG”), Multi-State Governmental Entities Group (“MSGE”), Ad Hoc Group of Individual Victims of Purdue Pharma, L.P. (“PI Ad Hoc Group”), Ad Hoc Committee of NAS Children (“NAS Children”), Ad Hoc Group of Hospitals (“Hospitals”), Third-Party Payor Group (“TPP Group”), and Ratepayer Mediation Participants (“Ratepayers”) all participated in the mediation as official Mediation Parties. The Native American Tribes Group (“Tribes Group”), Public School District Claimants (“Public Schools”), the National Association for the Advancement of Colored People, and others also participated in mediation, although not as official Mediation Parties. 20 1 Debtors, and several creditors, a group of twenty-five non-consenting states,
2 among others, rejected the agreement.
3 That agreement guaranteed that the Sacklers would contribute at least
4 $4.275 billion to the Debtors’ estate over approximately nine years. In exchange,
5 the Debtors’ plan of reorganization contained several nonconsensual releases (the
6 “Shareholder Release,” the “Release,” or the “Releases”) that, in effect,
7 permanently enjoined certain third-party claims against the Sacklers. As initially
8 proposed, the Release provisions were extremely broad and included the release
9 of claims pertaining to, inter alia, the same subject matter as any claim treated in
10 the plan; any business or other contractual arrangements including transfers; any
11 employment-related conduct; any pending opioid actions and opioid-related
12 activities; and the bankruptcy process.
13 In the third phase of the mediation, the Sacklers reached a modified
14 agreement with fifteen out of the twenty-five non-consenting states. 7 The new
15 terms of the modified settlement included additional payments of $50 million by
16 the Sacklers, and the accelerated payment of an additional $50 million from a
7The majority of the non-consenting states (California, Connecticut, Delaware, Maryland, Oregon, Rhode Island, Vermont, Washington, and the District of Columbia) (the “Nine”) maintained their objections to the plan and were parties to the appeal to the district court. 21 1 previously agreed-upon settlement payment. These modifications raised the
2 Sacklers’ aggregate contribution to the proposed plan to $4.325 billion. At that
3 time, no changes were made to the Shareholder Release.
4 Following mediation, a vote on the proposed plan was set in motion. Notice
5 of the confirmation hearing was published in the summer of 2021, with votes for
6 or against confirmation due by mid-July 2021, and reached 98% of adults in the
7 United States and 86% of adults in Canada. More than 120,000 votes were cast,
8 and each voting class voted “overwhelmingly” in favor of the plan. Special App’x
9 at 150–51 (“In the aggregate, the vote was over 95 percent in favor of confirmation
10 . . . . In each class the percent voting in favor of the plan was above 93 percent with
11 the exception of the class of hospital claims, which was over 88 percent . . . .”).
12 Ultimately, on September 1, 2021—after a confirmation hearing that
13 included the live testimony of 41 witnesses and extensive oral argument—the
14 bankruptcy court rendered an oral ruling stating that it would confirm the
15 proposed plan, but with a few changes. Most relevantly, the court modified the
16 Shareholder Release to ensure that the Debtors’ conduct must be a legal cause or
17 a legally relevant factor of any released cause of action against the Sacklers:
18 I . . . require that the shareholder releases . . . be further qualified than 19 they now are. To apply [only] where . . . a debtor’s conduct or the
22 1 claims asserted against it [are] a legal cause or a legally relevant factor 2 to the cause of action against the shareholder released party . . . . 3 4 Deferred Joint App’x at 1330–31. The new Shareholder Release thus read in
5 pertinent part:
6 [T]he Shareholder Released Parties . . . shall be conclusively, 7 absolutely, unconditionally, irrevocably, fully, finally, forever and 8 permanently released . . . from any and all Causes of Action, including 9 any derivative claims [and future claims] . . . (x) based on or relating 10 to, or in any manner arising from, in whole or in part, (i) the Debtors, 11 . . . (ii) the Estates or (iii) the Chapter 11 Cases and (y) as to which any 12 conduct, omission or liability of any Debtor or any Estate is the legal 13 cause or is otherwise a legally relevant factor. 14 15 Special App’x at 920.
16 B. Bankruptcy Court Order Confirming the Plan 8
17 The bankruptcy court confirmed its modified version of the proposed plan
18 (“the Plan”) on September 17, 2021, and issued an extensive opinion
19 memorializing its decision. See In re Purdue Pharma L.P. (“Purdue I”), 633 B.R. 53
20 (Bankr. S.D.N.Y. 2021) (Robert D. Drain, Bankr. J.).
21 The bankruptcy court order began by describing its task as “resolv[ing] the
22 collective problem presented by an insolvent debtor and a large body of creditors
23 competing for its insufficient assets . . . especially when there are mass claims
8This opinion describes the bankruptcy court’s opinion and the subsequent district court opinion only to the extent required to explain our reasoning today. 23 1 premised on . . . massive harm.” Purdue I, 633 B.R. at 58. The court found that
2 the confirmation hearing established that the Plan was the only “reasonably
3 conceivable” way to resolve the issues in the case, id. at 59, and, in doing so,
4 grounded its opinion on the principle that, in bankruptcy, courts “focus the
5 solution away from individual litigations to a fair collective result subject to the
6 unique ability under bankruptcy law to bind holdouts under well-defined
7 circumstances who could not otherwise be bound under non-bankruptcy law.” Id.
8 at 58.
9 1. Equitable Considerations
10 From there, the bankruptcy court asked whether the terms of the Plan
11 created an equitable plan and answered in the affirmative. Purdue I, 633 B.R. at
12 84–95. The court explained that to approve a settlement, a bankruptcy court must
13 determine whether the proposed terms are fair, equitable, and in the estate’s best
14 interest. Id. at 84. Here, in exchange for the Shareholder Release, the terms
15 included:
16 $4.325 billion, coupled with the Sackler[s’] other agreements, 17 including the dedication of the two charities worth at least $175 18 million for abatement purposes, the Sacklers’ agreement to a 19 resolution on naming rights, their agreement not to engage in any 20 business with NewCo [Purdue’s successor company], their 21 agreement to exit their foreign companies within a prescribed time, 22 their agreement to various ‘snap back’ protections to ensure the 24 1 collectability of their settlement payments, and their agreement to an 2 unprecedented extensive document depository accessible to the 3 public that will archive in a comprehensive way the Debtors’ history, 4 including as it relates to the development, production, and sale of 5 opioids. 6 7 Id. The bankruptcy court also highlighted the extensive mediation and discovery
8 processes that led to the development of these terms. Id. at 85–87.
9 As a legal framework for balancing the equities and determining whether to
10 approve the plan, the court was guided by the factors from In re Iridium Operating
11 LLC, 478 F.3d 452, 464–66 (2d Cir. 2007):
12 (1) The probability of success, should the issues be litigated, versus 13 the present and future benefits of the settlement; (2) the likelihood of 14 complex and protracted litigation if the settlement is not approved, 15 with its attendant expense, inconvenience and delay, including the 16 difficulty of collecting on a judgment; (3) the interests of the creditors, 17 including the degree to which creditors support the proposed 18 settlement; (4) whether other interested parties support the 19 settlement; (5) the competence and experience of counsel supporting, 20 and the experience and knowledge of the court in reviewing, the 21 settlement; (6) the nature and breadth of the releases to be obtained 22 by officers and directors or other insiders; and (7) the extent to which 23 the settlement is the product of arms-length bargaining. 24 25 Purdue I, 633 B.R. at 85.
26 In applying the Iridium factors, the bankruptcy court observed that, in this
27 case, counsel on both sides were experienced and formidable. Id. at 86–87. Over
28 95% of the voters approved the Plan, showing clear creditor support, and the
25 1 potential difficulty in collecting from the Sacklers and their related entities on any
2 successfully litigated claims was an issue of “significant concern.” Id. at 89. The
3 court noted that while the Sacklers are worth approximately $11 billion, they are
4 a large family whose assets are “widely scattered and primarily held” in
5 spendthrift trusts—both offshore and in the United States—that are largely
6 unreachable via bankruptcy proceedings. 9 Id. at 88. Moreover, certain members
7 of the Sackler family live “outside of the territorial jurisdiction of the United States
8 and might not have subjected themselves sufficiently to the U.S.” such that a U.S.
9 court would have personal jurisdiction over them. Id. And, perhaps most
10 importantly, according to the court, continued litigation—even if it were limited
11 to the claims at issue—would be extremely expensive and lead to delays. Id. at 89–
12 90. Thus, the court reasoned, an order against confirmation would not only
13 destroy the entire settlement but would also result in a major escalation of costs
14 and time. Id.
15 The bankruptcy court also noted that, in exchange for the Shareholder
16 Release, the Sacklers were contributing “the largest amount that shareholders have
17 ever paid in such a context of these types of third party claims and closely related
9Spendthrift trusts in the United States may be recovered from, however, if the transfers to such trusts are fraudulent. Id. at 88–89. 26 1 claims” and that “the non-monetary consideration under the settlement also is
2 substantial.” Id. at 107. And, according to the bankruptcy court’s findings,
3 without approval of the Plan including the Release, Purdue would be forced into
4 liquidation, the DOJ would recover its $2 billion claim first, and recovery by all
5 other creditors would be extremely limited because it would not be supplemented
6 with Sackler funds. Id. at 108–09; see also id. at 84 (“Without the $4.325 billion being
7 paid by the Sacklers under the plan and the other elements of the Sackler
8 settlements, those other elements of the plan would not happen. The record is
9 clear on that.”). Thus, the court concluded that, in a world without the Plan, the
10 Sacklers would likely be mired in litigation, but it would also be likely that they
11 could successfully shield much of their estimated $11 billion fortune from
12 creditors through spendthrift trusts and offshore accounts, and broader creditor
13 recovery from Purdue’s estate would be extremely limited due to the DOJ’s
14 superpriority. Id. at 84, 109.
15 2. The Authority of the Bankruptcy Court to Release Third-Party 16 Claims Against the Sacklers
17 The bankruptcy court next turned to the Plan’s release of third-party claims
18 against the Sacklers, which included all claims that had by then been asserted in
19 litigations against the Sacklers by third parties. The Release encompassed both
27 1 those based on a direct injury to the third-party claimant and those where the claim
2 properly lay with the Debtors (including, for example, whether the Sacklers
3 fraudulently transferred Purdue funds to family spendthrift trusts and other
4 offshore accounts). Purdue I, 633 B.R. at 91–95. This overview of claims led the
5 court to the thornier legal issue: whether direct claims by a third-party against a
6 non-debtor (here, the Sacklers) could ever be released through the bankruptcy
7 process. Id. at 95.
8 In addressing the question of its own authority, the bankruptcy court first
9 evaluated threshold arguments and determined that it had subject-matter
10 jurisdiction over the released claims. Id. at 95–98. But, in so finding, the court
11 narrowed the Release even further to cover only those claims that directly affect
12 the res—these claims included “insurance rights” and “the shareholder released
13 parties’ rights to indemnification and contribution” from the Debtors. Id. at 97.
14 Likewise, the court noted that “the Debtors’ ability to pursue the estates’ own
15 closely related, indeed fundamentally overlapping, claims” against the Sacklers
16 also directly affected the res. Id. at 97–98. The court did not exclude derivative
17 claims from the Release, reasoning that those claims were similarly likely to affect
18 the res. Id. at 98.
28 1 The bankruptcy court next addressed the objectors’ due process arguments
2 and found that they reduced to two claims—neither of which it found meritorious.
3 Id. at 98–99. The first due process claim argued that the Release was an
4 impermissible “adjudication of the claim.” Id. at 98. The court disagreed, and
5 instead characterized a release as “part of the settlement of the claim that channels
6 the settlement funds to the estate.” Id. As such, the bankruptcy court held that the
7 Release did not rule on the underlying merits of the claims being released. Id. The
8 objectors’ second due process argument claimed that there was inadequate notice.
9 Id. at 98–99. The court found adequate notice because the holders of claims against
10 the Debtors had received notice of “the plan’s intention to provide a broad release
11 of third-party claims against the shareholders” and other “entities related to the
12 Debtors.” Id. at 98. As the final part of its due process analysis, the bankruptcy
13 court also found that the claims released by the Plan were constitutionally core
14 claims, so the bankruptcy court had the constitutional power to issue “a final order
15 under Article III of the Constitution.” Purdue I, 633 B.R. at 99–100.
16 After clearing the constitutional hurdles, the bankruptcy court began its
17 analysis of statutory authority by noting that the majority of Circuits permit
18 nonconsensual third-party releases, while only three Circuits—the Fifth, Ninth,
29 1 and Tenth—do not. Id. at 100–01. The bankruptcy court concluded that the
2 provision of the Bankruptcy Code relied upon by that minority, 11 U.S.C. § 524(e),
3 is not a statutory impediment to third-party releases. Id. at 101–02.
4 The bankruptcy court instead looked to 11 U.S.C. § 105(a) and § 1123(b)(6)
5 as two potential sources of a bankruptcy court’s equitable authority to approve the
6 releases. Id. at 102–05. Following a review of pertinent case law, the bankruptcy
7 court held that so long as the releases are limited to those claims legally
8 intertwined with the Debtors’ conduct, they are appropriately subject to
9 settlement under both statutory and common law frameworks. Id. at 103–05.
10 The bankruptcy court then looked to this Court’s decision in In re Metromedia
11 Fiber Network, Inc., 416 F.3d 136 (2d Cir. 2005), and other case law from this Circuit,
12 to determine which factors a bankruptcy court should consider when determining
13 whether third-party releases are appropriate. Id. at 105–06. The court identified
14 the following factors: (1) the third-party releases were narrowly tailored; (2)
15 monetary contributions were critical to the Plan; (3) the success of the Plan hinged
16 on the third-party releases; (4) the affected class or classes overwhelmingly
17 accepted the Plan; (5) the amount being paid under the Plan was substantial
18 (which, the court noted, is not determined by the Sacklers’ net worth because
30 1 defendants’ wealth should not dictate settlement terms); and (6) claimants would
2 be compensated fairly under the Plan. Id. at 106–09.
3 Evaluating those factors, the bankruptcy court found that they supported
4 approval of the Plan. It pointed to the significant overlap in third-party claims
5 against both the Debtors and the Sacklers, chiefly that: (1) claims against both
6 derived from the Debtors’ conduct, and (2) to the extent that one or more of the
7 Sacklers could be said to have directed that conduct, or to have possessed the
8 knowledge and power to do so, the Sacklers’ and Debtors’ defenses would be the
9 same. Id. at 108. And it added that the potential difficulty, as discussed above, of
10 collecting on any judgment, the existence of spendthrift trusts, and the Estate’s
11 limited resources that the litigation process would likely deplete, also weighed in
12 favor of approval of the Plan. Id. at 108–09.
13 In sum, the bankruptcy court predicated confirmation of the Plan on a few
14 limitations to the third-party releases (namely that the Debtors’ conduct amount
15 to a legally relevant factor to a released cause of action and that the settled claims
16 affect the res), but otherwise—having established its authority to do so—
17 confirmed the Plan. Id. at 115.
31 1 3. Canadian Creditors’ Objections
2 The bankruptcy court also rejected the objections of certain Canadian
3 municipalities and First Nations (the “Canadian Creditors”) to the Plan, which
4 were essentially based on an argument that the Plan improperly classified their
5 claims. Id. at 69–72. Specifically, they objected on the basis that those claims
6 should have been classified like the claims of American non-federal governmental
7 creditors and tribal entities, such that they could participate in abatement trusts.
8 Id. at 69. Yet, the bankruptcy court observed that, even if the Canadian claims had
9 been otherwise classified, notwithstanding the resulting change in the Canadian
10 Creditors’ voting status, the Plan still would have been approved. Id. The
11 bankruptcy court’s reasons for classifying the Canadian claims separately boiled
12 down to: (1) different regulatory regimes of the United States and Canada, and (2)
13 that the Canadian Creditors did not participate in the mediation process. Id. at 70.
14 The bankruptcy court also noted that certain decisions to recognize or confirm the
15 Plan would be left to the Canadian courts. Id. at 71.
16 4. Pro Se Objections
17 Several pro se parties also objected to the Plan, but the bankruptcy court
18 similarly found their objections to be without merit. For example, one pro se
19 objector asserted that it was improper and unfair that the Plan provided only $700–
32 1 $750 million to a particular claimant group’s personal injury claims. Id. at 78. The
2 bankruptcy court looked to the length of the mediation, rigor of the legal analysis
3 and negotiation, and quality of mediators and lawyers, all to support that the
4 valuation of personal injury claims was reasonable. Id. at 78–79. Another pro se
5 objector claimed that releasing the Sacklers from civil liability under the Plan was
6 unfair and should not be approved because this plan is “the Sacklers’ plan.” Id. at
7 82. However, the bankruptcy court disagreed and emphasized that the Plan was
8 “not the Sacklers’ plan” because it involved an arms-length negotiation among all
9 interested parties with three experienced mediators. Id. at 82–83 (emphasis in
10 original).
11 C. District Court Order Rejecting the Plan
12 In a December 16, 2021 opinion, the district court vacated the bankruptcy
13 court’s decision to confirm the Plan. In re Purdue Pharma, L.P. (“Purdue II”), 635
14 B.R. 26 (S.D.N.Y. 2021) (Colleen McMahon, J.). Principally, the court ruled that no
15 statutory authority permits third-party releases such as the ones found in the Plan.
16 Id. at 89–90. The court based its reasoning on two propositions: first, that the
17 Bankruptcy Code does not expressly allow such releases; and second, that this
18 Circuit’s case law “has not yet been required to identify any source [in the
19 Bankruptcy Code] for [the] authority” to grant such releases. Id. 33 1 1. Subject-Matter Jurisdiction
2 The district court’s analysis of statutory authority was preceded by the
3 preliminary question of the bankruptcy court’s jurisdictional reach under the
4 Bankruptcy Code to release the claims encompassed by the Shareholder Release.
5 The district court agreed that the bankruptcy court had subject-matter jurisdiction
6 over all claims because: (1) the third-party claims raised questions as to the
7 distribution of the Estates’ property, id. at 85; (2) the third-party claims might have
8 altered the liabilities of the Debtors and changed the amount available from the
9 res, id. at 85–86; (3) the claims had a high degree of interconnectedness with claims
10 against the Debtors, id. at 86–87; and (4) Purdue’s insurance obligations to
11 members of the Sacklers who were officers of Purdue could have burdened the res.
12 Id. at 87–88. Accordingly, having found that the release of the third-party claims
13 “might have some conceivable effect on the estate of a debtor,” the district court
14 concluded that they fell within the bankruptcy court’s jurisdiction. Id. at 89
15 (emphasis in original).
16 2. Statutory Power to Release Third-Party Claims
17 Turning to the primary issue in this appeal, the district court next ruled that
18 the bankruptcy court did not have statutory authority to release third-party direct
19 claims against the Sacklers because the Sacklers were not the Debtors, and the
34 1 Bankruptcy Code does not authorize the “non-consensual” release of
2 “direct/particularized claims asserted by third parties against non-debtors.” Purdue II,
3 635 B.R. at 90 (emphasis in original).
4 The district court’s analysis on this issue considered the case law from this
5 Court, the Supreme Court, and other circuit courts. It characterized this Court’s
6 holding in Metromedia as indicating that third-party releases could be permissible,
7 but as being inconclusive as to whether “such releases [a]re consistent with or
8 authorized by the Bankruptcy Code.” Purdue II, 635 B.R. at 101. And, to the extent
9 that Metromedia suggested that such releases would be permissible in “unique
10 instances,” the district court viewed the opinion as having failed to identify what
11 those instances are. Id. (internal quotation marks omitted). Due to this perceived
12 lack of clarity, the district court concluded that “while Metromedia said a great deal,
13 the case did not hold much of anything,” id., and thus a bankruptcy court’s
14 statutory authority to impose third-party releases is “questionable.” Id at 89.
15 Moving on to the Supreme Court, the district court acknowledged that
16 although the Court has never spoken directly on whether the Bankruptcy Code
17 provides authority for these types of releases, it has held, “albeit in contexts
18 different from the one at bar, that a bankruptcy court lacks the power to award
35 1 relief that varies or exceeds the protections contained in the Bankruptcy Code,”
2 and it lacks such power “even in ‘rare’ cases, and [ ] even when those orders would
3 help facilitate a particular reorganization.” Id. at 94–96 (citing Law v. Siegel, 571
4 U.S. 415 (2014) and Czyzewski v. Jevic Holding Corp., 580 U.S. 451 (2017)).
5 At bottom, the district court concluded that no section of the Bankruptcy
6 Code expressly or impliedly provided the requisite statutory authority for the
7 Releases. Id. at 115. The district court also rejected the argument that the
8 bankruptcy court possessed residual equitable authority to impose the Releases.
9 Id. at 112–14. The district court further ruled that the fact that the Plan required
10 the Releases for confirmation did not vest the bankruptcy court with authority to
11 approve them. Id. at 108–09.
12 3. Classification of Canadian Claims
13 Finally, the district court agreed with the bankruptcy court that the
14 Canadian Appellants’ claims were properly classified differently than those of the
15 domestic claimants, and that all the Bankruptcy Code requires is a reasonable basis
16 for differentiation. Id. at 116–17. The equal treatment mandate applies only to
17 creditors within the same class, and the district court held that, under this Court’s
18 precedent, there was a reasonable basis to differentiate the Canadian creditors’
36 1 claims because different regulatory regimes apply, and because the mediation
2 solely involved U.S.-based claimants. Id.
3 This Appeal followed.
4 D. This Appeal
5 The Appellants include a variety of interests unified in favor of the
6 confirmation of the Plan: the Debtors, the Official Committee of Unsecured
7 Creditors (the “UCC”), 10 the Ad Hoc Committee of Governmental and Contingent
8 Litigation Claimants (the “AHC”), 11 the Ad Hoc Group of Individual Victims of
9 Purdue Pharma, L.P. (“Pl. Ad Hoc Group”), 12 the Multi-State Governmental
10 The UCC is composed of eight dedicated members, including individuals who are themselves (or whose loved ones are) victims of the opioid epidemic, representatives of a trade association for 35 independent health insurance companies collectively insuring 110 million members, a member of one of the largest hospital systems in the United States, the Pension Benefit Guaranty Corporation (the federal entity responsible for insuring defined benefit pension plans), a co-defendant in opioid litigation that has asserted indemnification claims against the Debtors, and three ex officio members that represent political subdivisions, tribes, and public school districts. 11 The AHC is composed of ten States, the court-appointed Plaintiffs’ Executive
Committee in the multi-district litigation captioned In re National Prescription Opiate Litigation, Case No. 17-md-02804 (DAP) (N.D. Ohio), six counties, cities, parishes, or municipalities, and one federally recognized American Indian Tribe. 12 This group comprises over 60,000 individuals who were injured by direct exposure to
Purdue’s opioid products, who together make up approximately one-half of those who filed personal injury claims in Purdue’s Chapter 11 Cases. 37 1 Entities Group (the “MSGE”), 13 the Mortimer-side Initial Covered Sackler Persons
2 (the “Mortimer Sacklers”), and the Raymond Sackler Family (the “Raymond
3 Sacklers,” and together with the Mortimer Sacklers, the “Sacklers” or “Sackler
4 family”).
5 While this Appeal was pending, eight states—California, Connecticut,
6 Delaware, Maryland, Oregon, Rhode Island, Vermont, and Washington—and the
7 District of Columbia (the “Nine”) that had appealed the confirmation of the
8 original settlement, the Debtors, and the Sacklers filed a new settlement agreement
9 with the bankruptcy court that provided for an additional $1.175–$1.675 billion in
10 Sackler contributions (resulting in an aggregate $5.5 to $6.0 billion contribution to
11 the Plan). See Order Pursuant to 11 U.S.C. §§ 105 and 363(b) Authorizing and
12 Approving Settlement Term Sheet, In re Purdue Pharma L.P., No. 19-23649 (Bankr.
13 S.D.N.Y. Mar. 10, 2022), ECF No. 4503. The bankruptcy court granted the motion
14 to confirm the revised plan but noted that its confirmation would require one or
15 more orders by this Court or the district court. Id. As part of the revised settlement
13 Members of the MSGE Group are creditors of the Debtors, and many filed prebankruptcy lawsuits against them for their role in fostering the nationwide opioid crisis. 38 1 agreement, the Nine agreed to withdraw their opposition to the Plan, including
2 the Shareholder Releases. Id.
3 As a result, the Appellees currently left defending the district court’s
4 decision include only U.S. Trustee William K. Harrington (“the Trustee”), 14 several
5 Canadian municipalities and indigenous nations (the “Canadian Creditors”), and
6 several individual pro se personal injury claimants (Ronald Bass, Ellen Isaacs,
7 Maria Ecke, Richard Ecke, Andrew Ecke, the Estate of David Jonathan Ecke, and
8 Peter Sottile).
9 DISCUSSION
10 I. Standard of Review
11 A. The Bankruptcy Court’s Adjudicatory Authority
12 As stated by the district court, to the extent claims encompassed by the
13 third-party releases are non-core under Stern v. Marshall, the bankruptcy court was
14 required to submit “proposed findings of fact and conclusions of law to the district
14Congress has authorized the Attorney General to appoint U.S. Trustees, who are Department of Justice officials, to supervise the administration of bankruptcy cases. 28 U.S.C. §§ 581–589a. U.S. Trustees “serve as bankruptcy watch-dogs to prevent fraud, dishonesty, and overreaching in the bankruptcy arena.” H.R. Rep. No. 95-595, at 88 (1977). They “may raise and may appear and be heard on any issue in any case or proceeding” brought under the Bankruptcy Code. 11 U.S.C. § 307. Congress specifically empowered U.S. Trustees to comment on proposed disclosure statements and Chapter 11 plans of reorganization. 28 U.S.C. § 586(a)(3)(B). 39 1 court, for that court’s [de novo] review and issuance of final judgment.” 564 U.S.
2 462, 471 (2011). Stern defines core claims as those stemming “from the bankruptcy
3 itself” or those which “would necessarily be resolved in the claims allowance
4 process.” Id. at 499. For substantially the same reasons articulated by the district
5 court, see Purdue II, 635 B.R. at 79-83, we agree that the bankruptcy court lacked
6 constitutional authority to finally approve of the releases, and, therefore, that the
7 district court correctly construed the bankruptcy court’s decision as setting forth
8 its proposed findings of fact and conclusions of law for the district court’s de novo
9 review. In short, the released claims at issue here—which, pursuant to the Plan,
10 are permanently enjoined, have res judicata effect, and, as such, are effectively
11 finally resolved—do not stem “from the bankruptcy itself,” Stern, 564 U.S. at 499,
12 but are direct claims, arising under state law, against non-debtors held by third
13 parties who have not sought to recover on those claims in bankruptcy, or
14 otherwise consented to a bankruptcy court’s adjudication of those claims.
15 It is true, as Debtors note, that the resolution of the third-party claims might
16 impact the res of the Estate—a fact determinative of the district court’s statutory
17 jurisdiction under the Code—but the same was true for the counterclaims held in
18 Stern to be beyond the bankruptcy court’s constitutional reach to finally
40 1 determine. To the point, had the debtor in Stern been successful on her
2 counterclaim against the creditor, the value of the estate would have been
3 impacted; she would have had a property interest in the resulting damages award,
4 which would have, in turn, increased the value of her estate. See id. The focus of
5 the constitutional analysis in Stern does not turn on the extent to which the non-
6 core claim might alter the creditor-debtor relations in a given bankruptcy. That
7 said, we agree with the district court that the practical import of the Stern issue is
8 nonexistent given that only conclusions of law are at issue here, requiring our de
9 novo review under any standard. See Purdue II, 635 B.R. at 82 n.54.
10 B. Appellate Review of the District Court
11 In an appeal from a district court’s review of a bankruptcy court’s decision,
12 this Court “independently” reviews the bankruptcy court’s conclusions of law de
13 novo and its factual findings for clear error. Morning Mist Holdings Ltd. v. Krys (In
14 re Fairfield Sentry Ltd.), 714 F.3d 127, 132 (2d Cir. 2013). A factual finding is clearly
15 erroneous when “the reviewing court on the entire evidence is left with the definite
16 and firm conviction that a mistake has been committed.” United States v. U.S.
17 Gypsum Co., 333 U.S. 364, 395 (1948). “[I]n reviewing factual findings for clear
18 error, an appellate court is not confined to evidence cited in a lower court’s
41 1 opinion, but must instead review all of the record evidence.” Bankr. Servs, Inc. v.
2 Ernst & Young (In re CBI Holding Co.), 529 F.3d 432, 449 (2d Cir. 2008).
3 This Court may uphold a bankruptcy court decision on any ground—even
4 one not relied upon by the district court. Resol. Tr. Corp. v. Best Prods. Co. (In re Best
5 Prods. Co.), 68 F.3d 26, 30 (2d Cir. 1995). As such, we decide all pertinent issues
6 necessary to confirm the Plan and do not limit our analysis solely to the issues
7 addressed below.
8 II. Nonconsensual Third-Party Releases of Direct Claims
9 The two primary questions posed on appeal are: (1) whether the bankruptcy
10 court had the authority to approve the nonconsensual release of direct third-party
11 claims against the Sacklers, a non-debtor, through the Plan; and (2) whether the
12 text of the Bankruptcy Code, factual record, and equitable considerations support
13 the bankruptcy court’s approval of the Plan. We answer both in the affirmative.
14 To explain our reasoning, we begin by describing the scope of the
15 Shareholder Releases (including the types of claims covered and the claims at issue
16 here). We then address the various statutory and constitutional arguments raised
17 by the parties. Finally, we evaluate the bankruptcy court’s findings regarding the
42 1 fairness and equitable nature of the Plan, and we articulate factors to help guide
2 future courts evaluating similar issues.
3 A. The Scope of the Releases
4 The original version of the Release from the September 2, 2021 Plan of
5 Reorganization settles
6 any and all Causes of Action, including . . . [present and future 7 claims], (x) based on or relating to, or in any manner arising from, in 8 whole or in part, (i) the Debtors, . . . (including the Debtors’ Opioid- 9 Related Activities, manufacture, marketing and sale of Products, 10 interaction with regulators concerning Opioid-Related Activities or 11 Products, and involvement in the subject matter of the Pending 12 Opioid Actions, and the past, present or future use or misuse of any 13 opioid by a Releasing Party) . . . and (y) as to which any conduct, 14 omission or liability of any Debtor or any Estate is the legal cause or 15 is otherwise a legally relevant factor. 16 17 Special App’x at 920. As discussed supra, the bankruptcy court subsequently
18 limited the releases such that they only “apply where . . . a debtor’s conduct or the
19 claims asserted against it [are] a legal cause or a legally relevant factor to the cause
20 of action against the shareholder released party,” Deferred Joint App’x at 1330–31,
21 and the released claims directly affect the res, Purdue I, 633 B.R. at 97–98.
22 The released claims can be grouped into two categories: direct claims and
23 derivative claims. In this context, direct claims are causes of action brought to
24 redress a direct harm to a plaintiff caused by a non-debtor third party. See Marshall
43 1 v. Picard (In re Bernard L. Madoff Inv. Secs. LLC), 740 F.3d 81, 89 n.9 (2d Cir. 2014).
2 By contrast, derivative claims are “ones that arise from harm done to the estate
3 and that seek relief against [the] third part[y] that pushed the debtor[s]
4 into bankruptcy.” Id. at 89 (internal quotation marks and alterations omitted); see
5 also Tronox Inc. v. Kerr-McGee Corp. (In re Tronox Inc.), 855 F.3d 84, 100-04 (2d Cir.
6 2017) (explaining the law of derivative claims in the bankruptcy context). The
7 potential claims released against the Sacklers include, inter alia, fraudulent
8 transfer, constructive fraudulent transfer, deceptive marketing, public nuisance,
9 unfair competition, fraudulent misrepresentation, violation of state consumer
10 protection acts, civil conspiracy, negligence, and unjust enrichment. Some of these
11 claims are direct, and some are derivative. As conceded by the parties, fraudulent
12 transfer claims, for example, are typically derivative claims in that the real injury
13 is to the Debtors’ estate, 15 and it is well-settled that a bankruptcy court may
14 approve not only third-party releases which are consensual, but also third-party
15 releases of derivative claims because those claims really belong to the estate of the
15 Although the Plaintiff Ad Hoc Group contends that the district court erred in concluding the claims against the Sacklers are not all derivative, we find no error because certain consumer protection act claims at a minimum constitute direct claims in that the injury belongs directly to the claimant, and not to the Debtors. We need not define the exact claims which fall under the umbrella of direct claims but note that certain state law claims under consumer protection acts likely do. 44 1 debtor. See, e.g., 11 U.S.C. § 1123(b)(3)(A) (permitting release of claims as to the
2 estate’s property); Madoff, 740 F.3d at 88 (“A claim based on rights derivative of,
3 or derived from, the debtor’s typically involves property of the estate. By contrast,
4 a bankruptcy court generally has limited authority to approve releases of a non-
5 debtor’s independent claims.” (internal citation and quotation marks omitted)).
6 The more controversial issue, however, is this Plan’s likely release of some direct
7 claims against the Sacklers.
8 The bankruptcy court’s ability to release claims at all derives from its power
9 of discharge. See generally 11 U.S.C. § 524(a). Under the Bankruptcy Code, a
10 bankruptcy discharge releases a debtor from personal liability with respect to any
11 debt by enjoining creditors from attempting to collect on that debt, so long as the
12 debtor discloses all its financial information and puts those assets towards its
13 estate. 11 U.S.C. § 524; Tenn. Student Assistance Corp. v. Hood, 541 U.S. 440, 447
14 (2004) (“The discharge order releases a debtor from personal liability with respect
15 to any discharged debt by voiding any past or future judgments on the debt and
16 by operating as an injunction to prohibit creditors from attempting to collect or to
17 recover the debt.”); see also 11 U.S.C. §§ 521–523. This extraordinary remedy is
18 based on bankruptcy courts’ in rem jurisdiction over the property of the debtor.
45 1 While the Bankruptcy Code forbids a discharge of a non-debtor’s claim under 11
2 U.S.C. § 524(e), the releases at issue on appeal do not constitute a discharge of debt
3 for the Sacklers because the releases neither offer umbrella protection against
4 liability nor extinguish all claims. See MacArthur Co. v. Johns-Manville Corp.
5 (“Manville I”), 837 F.2d 89, 91 (2d Cir. 1988) (ruling that the bankruptcy court had
6 the authority to enjoin third-party claims because “the injunctive orders d[id] not
7 offer the umbrella protection of a discharge in bankruptcy” and were instead
8 limited to suits “that ar[o]se out of or relate[d] to” specific issues central to the
9 bankruptcy).
10 Thus, the primary dispute is whether direct claims brought by creditors of
11 Purdue against the Sacklers (for which the Debtors’ conduct is legally relevant)
12 can be released. As described in the following sections, we conclude that the
13 bankruptcy court possessed both jurisdiction and statutory authority to approve
14 the Releases because the limitations on the scope of the releases are significant and
15 no other argument bars their imposition.
16 B. Subject-Matter Jurisdiction
17 As an initial matter, we must ensure the bankruptcy court had subject-
18 matter jurisdiction, pursuant to the Bankruptcy Code, over the released claims.
19 See Joseph v. Leavitt, 465 F.3d 87, 89 (2d Cir. 2006) (“[W]e have an independent 46 1 obligation to consider the presence or absence of subject matter jurisdiction sua
2 sponte.”).
3 A bankruptcy court’s subject-matter jurisdiction under the Code is broad. It
4 extends to all civil actions so long as “the action’s outcome might have any
5 conceivable effect on the bankrupt estate.” Parmalat Cap. Fin. Ltd. v. Bank of Am.
6 Corp., 639 F.3d 572, 579 (2d Cir. 2011) (internal quotation marks omitted); see also
7 28 U.S.C. §§ 157(a), 1334. However, that jurisdictional reach is not endless: a
8 bankruptcy court may only “enjoin third-party non-debtor claims that directly
9 affect the res of the bankruptcy estate.” Johns-Manville Corp. v. Chubb Indemnity Ins.
10 Co. (“Manville III”), 517 F.3d 52, 66 (2d Cir. 2008). That limitation is in line with the
11 goal that “extending bankruptcy jurisdiction to actions against certain third
12 parties, as well as suits against debtors themselves, is to protect the assets of the
13 estate so as to ensure a fair distribution of those assets at a later point in time.”
14 Pfizer Inc. v. Law Offices of Peter G. Angelos (In re Quigley Co.), 676 F.3d 45, 57 (2d
15 Cir. 2012) (internal quotation marks and alteration marks omitted).
16 A direct claim brought against non-debtors, such as the Sacklers, “that
17 nevertheless poses the specter of direct impact on the res of the bankrupt estate
18 may just as surely impair the bankruptcy court’s ability to make a fair distribution
47 1 of the bankrupt’s assets as a third-party suit alleging derivative liability.” Id. at 58.
2 Accordingly, if, for example, the litigation of the settled claims “would almost
3 certainly result in the drawing down of . . . the bankruptcy estate of [the debtor],
4 the exercise of bankruptcy jurisdiction to enjoin [third-party direct claims is]
5 appropriate.” Id. Thus, as to statutory jurisdiction, our key inquiry is into the
6 likely impact on the res.
7 We agree with both the bankruptcy court and the district court that the
8 bankruptcy court had statutory jurisdiction to impose the Releases because it is
9 conceivable, indeed likely, that the resolution of the released claims would directly
10 impact the res.
11 First, as both courts below noted, at least some of the third-party claims,
12 although directly asserted against the Sacklers, are closely related to the derivative
13 claims which the Estate might bring against the Sacklers. For example, many of
14 the states that, below, objected to the Plan (but have since withdrawn their claims
15 in favor of settlement) have laws which impose direct liability on individuals who,
16 as officers of a corporation, personally participated in acts of corporate fraud. See,
17 e.g., U.S. Trustee’s App’x at 2644–47, 2765, In re Purdue Pharma L.P., No. 21-07532
18 (S.D.N.Y. Sept. 9, 2021), ECF Nos. 91-7, 91-8. However, although the various state
48 1 statutes ensure that managerial personnel can be held independently liable for the
2 same conduct that subjects the corporation to liability, those claims often “rely on
3 detailed and virtually identical set of facts to make the claims” against both Purdue
4 and the Sacklers. Purdue II, 635 B.R. at 86. As a result of that substantial overlap,
5 the litigation of third-party direct claims against the Sacklers would likely impact
6 the Debtor’s ability to pursue, and the likelihood of recovering on, the Estate’s own
8 Second, the Sacklers are covered by the Sackler-Purdue Indemnity
9 Agreement, and, therefore, depending on the outcome of any given claims against
10 them, would have a reasonable basis to seek indemnification from the Debtors.16
11 That possibility is enough to implicate the bankruptcy court’s “related to”
12 jurisdiction under our precedent. See SPV Osus Ltd. v. UBS AG, 882 F.3d 333, 341-
13 42 (2d Cir. 2018). 17
16 In addition to indemnification claims, the Sacklers might also assert claims against the Estate for either insurance coverage or contribution. See generally Appellees’ Suppl. App’x at 627–35, Bryant Dunaway v. Purdue Pharma L.P. (In re Purdue Pharma L.P.), No. 19- 10941 (CM) (S.D.N.Y. June 22, 2020), ECF No. 24-2. 17 In SPV, the plaintiffs asserted direct claims against, among other defendants, UBS AG,
alleging principally that UBS had aided and abetted the infamous fraud perpetrated by the debtor, Bernard L. Madoff Investment Securities LLC. See SPV, 992 F.3d at 338. Although the plaintiffs sought recovery from UBS itself, UBS, in turn, had viable claims for indemnification and contribution against the debtor. See id. at 340–42. The possibility that those claims might have succeeded—and the fact that the debtor would incur 49 1 To be sure, the Indemnity Agreement plainly bars any indemnification
2 obligation flowing from the Debtors to the Sacklers where a court determines the
3 Sacklers “did not act in good faith.” SA 629. Consequently, as to any successful
4 claims against the Sacklers sounding in fraud (such as the state consumer
5 protection claims), the Sacklers would not have any reasonable basis to seek
6 indemnification. Yet, as the district court noted, “the question of bad faith in this
7 case is hotly disputed.” Purdue II, 635 B.R. at 88. In the end, the jurisdictional issue
8 does not require us to resolve that question; the relevant inquiry is whether the
9 claims for indemnification “might have any conceivable effect on the bankrupt
10 estate.” SPV, 883 F.3d at 339-40 (emphasis added) (internal citation omitted). That
11 standard is plainly satisfied here.
12 C. Bankruptcy Code Authority
13 The ultimate authority for the imposition of nonconsensual releases of direct
14 third-party claims against non-debtors is rooted—as it must be—in the
15 Bankruptcy Code, specifically 11 U.S.C. §§ 105(a) and 1123(b)(6). Further
16 bolstering this statutory authority is this Circuit’s caselaw stating that a
17 bankruptcy court has authority to impose such releases.
expense in litigating such claims—was enough to confer jurisdiction on the bankruptcy court to enjoin the plaintiff’s direct claims against UBS. See id. at 341-42. 50 1 1. Statutory Authority
2 The bankruptcy court correctly grounded its authority for approving the
3 Releases in §§ 105(a) and 1123(b)(6), which provide the statutory basis for the
4 bankruptcy court’s equitable authority and permit the bankruptcy court’s
5 approval of the Plan. 11 U.S.C. § 105(a) states that “[t]he court may issue any order,
6 process, or judgment that is necessary or appropriate to carry out the provisions
7 of [the Bankruptcy Code].” 11 U.S.C. § 1123(b)(6) states that “a plan may . . .
8 include any other appropriate provision not inconsistent with the applicable
9 provisions of this title.” We deem Appellees’ arguments—that since the
10 Bankruptcy Code does not explicitly authorize third-party releases, they are
11 outside of a bankruptcy court’s statutory authority—unpersuasive.
12 First, although we have stated that § 105(a) gives “broad equitable power to
13 the bankruptcy courts to carry out the provisions of the Bankruptcy Code,”
14 Adelphia Bus. Sols., Inc. v. Abnos, 482 F.3d 602, 609 (2d Cir. 2007) (emphasis added),
15 we reject Appellants’ suggestion that § 105(a) alone supports the imposition of the
16 releases in this action. Indeed, our case law, and that of the majority of our sister
17 circuits, support the proposition that § 105(a) alone cannot justify the imposition
18 of third-party releases. See New England Dairies, Inc. v. Dairy Mart Convenience
19 Stores, Inc. (In re Dairy Mart Convenience Stores, Inc.), 351 F.3d 86, 92 (2d Cir. 2003) 51 1 (ruling that an exercise of § 105(a) power must “be tied to another Bankruptcy
2 Code section and not merely to a general bankruptcy concept or objective”); see,
3 e.g., Brown v. Viegelahn (In re Brown), 960 F.3d 711, 719–20 (5th Cir. 2020) (ruling
4 that bankruptcy courts must link Section 105(a) with another provision of the
5 Bankruptcy Code); Bird v. Carl’s Grocery Co. (In re NWFX, Inc.), 864 F.2d 593, 595
6 (8th Cir. 1989) (same); Southern Ry. Co. v. Johnson Bronze Co. (In re Johnson Bronze
7 Co.), 758 F.2d 137, 141 (3d Cir. 1985) (same). Thus, at least one other provision of
8 the Bankruptcy Code must provide the requisite statutory authority. Section
9 1123(b)(6) does.
10 As previously stated, 11 U.S.C. § 1123(b)(6) permits the inclusion of “any
11 other appropriate provision” in a plan so long as it is “not inconsistent” with other
12 sections of the Bankruptcy Code. In United States v. Energy Resources Co., Inc., the
13 Supreme Court held that this provision—acting in tandem with § 105(a)—grants
14 bankruptcy courts a “residual authority” consistent with “the traditional
15 understanding that bankruptcy courts, as courts of equity, have broad authority
16 to modify creditor-debtor relationships.” 495 U.S. 545, 549 (1990) (emphasis
17 added). 18 Thus, in Energy Resources, the Court, relying on § 1123(b)(6), permitted
18Energy Resources refers to 11 U.S.C. § 1123(b)(5). That provision was later recodified as § 1123(b)(6). 52 1 bankruptcy courts “to approve reorganization plans designating tax payments as
2 either trust fund or nontrust fund”—even absent express authorization from the
3 Bankruptcy Code. Id. at 545. Appellees, however, nevertheless argue that Energy
4 Resources does not permit reliance on § 1123(b)(6) because the third-party releases
5 at issue here are “not specifically authorized by the Code.” Trustee Br. at 48.
6 Appellees further maintain that Energy Resources only speaks to the ability of
7 bankruptcy courts to modify “creditor-debtor” relationships, and that these
8 releases go beyond such relationships. Trustee Br. at 54.
9 We are not persuaded by Appellees’ arguments. First, as the Court’s
10 language in Energy Resources indicates, § 1123(b)(6) is limited only by what the
11 Code expressly forbids, not what the Code explicitly allows. Second, and as the
12 Seventh Circuit convincingly has held, bankruptcy courts’ equitable powers under
13 § 1123(b)(6) include the power “to release third parties from liability.” Airadigm
14 Commc’ns, Inc. v. FEC (In re Airadigm Commc’ns, Inc.), 519 F.3d 640, 657 (7th Cir.
15 2008). The Sixth Circuit has also ruled that the residual authority grounded in
16 §§ 105(a) and 1123(b)(6) supports a bankruptcy court’s power to impose third-
17 party releases. Class Five Nev. Claimants (00-2516) v. Dow Corning Corp. (In re Dow
18 Corning Corp.), 280 F.3d 648, 656–58 (6th Cir. 2002) (concluding that third-party
53 1 releases can be appropriate, but that the factual findings presented did not support
2 them). Although our case law has never expressly cited § 1123(b)(6) to support
3 the imposition of third-party releases, we now explicitly agree with these Circuits
4 and conclude that § 1123(b)(6), with § 105(a), permit bankruptcy courts’
5 imposition of third-party releases.
6 Our sister circuits that have held that the Bankruptcy Code does not support
7 the imposition of nonconsensual third-party releases rely upon the provisions
8 limiting the discharge of debt under 11 U.S.C. § 524(e). See Bank of N.Y. Tr. Co. v.
9 Official Unsecured Creditors’ Comm. (In re Pac. Lumber Co.), 584 F.3d 229, 251–53 (5th
10 Cir. 2009); Resorts Int’l, Inc. v. Lowenschuss (In re Lowenschuss), 67 F.3d 1394, 1401–
11 02 (9th Cir. 1995); Landsing Diversified Props.-II v. First Nat’l Bank and Tr. Co. of Tulsa
12 (In re W. Real Estate Fund, Inc.), 922 F.2d 592, 600–02 (10th Cir. 1990). Section 524(e)
13 states that “discharge of a debt of the debtor does not affect the liability of any
14 other entity on, or the property of any other entity for, such debt.” 11 U.S.C. §
15 524(e).
16 This language assures that an entity also liable with a bankruptcy debtor for
17 “such debt” remains liable notwithstanding the debtor’s discharge of its
18 obligation. For example, the entity might be jointly liable for the debt.
54 1 The circuits that have read § 524(e) as a bar to third-party releases have
2 reasoned that “it is the debtor[] who has invoked and submitted to the bankruptcy
3 process, that is entitled to its protections; Congress did not intend to extend such
4 benefits to third-party bystanders.” In re W. Real Estate Fund, Inc., 922 F.2d at 600–
5 02 (quoting 11 U.S.C. § 524(e)); In re Pac. Lumber Co., 584 F.3d at 252 (“In a variety
6 of contexts, this court has held that Section 524(e) only releases the debtor, not co-
7 liable third parties. These cases seem broadly to foreclose non-consensual non-
8 debtor releases and permanent injunctions.” (internal citations omitted)); In re
9 Lowenschuss, 67 F.3d at 1401 (“This court has repeatedly held, without exception,
10 that § 524(e) precludes bankruptcy courts from discharging the liabilities of non-
11 debtors.”).
12 In contrast to these holdings, we do not consider 11 U.S.C. § 524(e) to be a
13 bar to such releases. As explained by the Seventh Circuit in Airadigm:
14 § 524(e) does not purport to limit the bankruptcy court’s powers to 15 release a non-debtor from a creditor’s claims. If Congress meant to 16 include such a limit, it would have used the mandatory terms “shall” 17 or “will” rather than the definitional term “does.” And it would have 18 omitted the prepositional phrase “on, or . . . for, such debt,” ensuring 19 that the “discharge of a debt of the debtor shall not affect the liability 20 of another entity”—whether related to a debt or not. 21
55 1 519 F.3d at 656. Moreover, “where Congress has limited the powers of the
2 bankruptcy court, it has done so clearly—for example, by expressly limiting the
3 court’s power . . . or by creating requirements for plan confirmation.” Id. (citing to
4 11 U.S.C. § 105(b) (“a court may not appoint a receiver in a case under this title”)
5 and 11 U.S.C. § 1129(a) (“The court shall confirm a plan only if the following
6 requirements are met”) as illustrative examples). Following this logic, we see no
7 reason grounded in the text of the Bankruptcy Code to bar the inclusion of third-
8 party releases in plans of reorganization.
9 2. Second Circuit Case Law
10 Despite the district court’s pronouncement to the contrary, Purdue II, 635 at
11 89, this Court’s precedents permit the imposition of nonconsensual third-party
12 releases. Appellants uniformly agree that our precedents support the approval of
13 a plan containing nonconsensual third-party releases. See, e.g., AHC Br. at 18
14 (“This Court has held on multiple occasions that third-party releases are allowed
15 in appropriate circumstances.”); Debtors Br. at 32 (“For more than three decades,
16 this Court has held that bankruptcy courts are authorized to enjoin and release
17 third-party claims against non-debtors, as part of a plan of reorganization, in
18 appropriate circumstances.”). But Appellees contend that such releases are the
19 equivalent of an inappropriate discharge, that this Circuit at no point has 56 1 permitted the release of direct third-party claims in non-asbestos actions, and that
2 no case supports a plan doing so here. Trustee Br. at 69–77; Canadian Creditors
3 Br. at 27–35. That reading is incorrect in the face of our case law, most explicitly
4 Drexel, where we concluded: “In bankruptcy cases, a court may enjoin a creditor
5 from suing a third party, provided the injunction plays an important part in the
6 debtor’s reorganization plan.” In re Drexel Burnham Lambert Group, Inc. (“Drexel”),
7 960 F.2d 285, 293 (2d Cir. 1992). Our opinions in Manville I and Metromedia further
8 confirm that such releases are neither discharges nor allowable only in the context
9 of asbestos cases.
10 Manville I stated that injunctive orders barring third-party claims are not
11 necessarily impermissible discharges. 837 F.2d at 91. There, we were presented
12 with a Chapter 11 bankruptcy plan that released over $2 billion in asbestos victims’
13 claims against the insurers of Manville, a distributor of asbestos products. 837 F.2d
14 at 90. While Manville was a debtor in the bankruptcy, its insurers were not. Id. at
15 91. Thus, to obtain the releases, the insurers paid Manville a $770 million
16 settlement. Id. at 94. Before this Court, the appellant (a distributor of Manville’s
17 products) challenged the bankruptcy court’s jurisdiction and authority by arguing
18 that the third-party releases operated as a bankruptcy discharge that cannot be
57 1 granted to non-debtors under the Bankruptcy Code. Id. at 91. We disagreed and
2 ruled that the releases did not constitute a bankruptcy discharge because they (1)
3 did not offer the umbrella protection of a discharge, and (2) did not extinguish the
4 claims against the insurer, but rather “channeled” them “away from the insurers
5 and redirected [them to] the proceeds of the settlement.” Id. at 91. Moreover, the
6 insurers’ rights were “completely derivative of” and “inseparable from” the
7 debtor’s rights. Id. at 92–93. Thus, plaintiffs’ released claims fell well-within the
8 bankruptcy court’s jurisdiction over the debtor’s estate. Id.
9 We also stated in Manville I that the bankruptcy court properly imposed the
10 releases under the Bankruptcy Code. While the bankruptcy court primarily relied
11 on § 363(f)—which permits channeling orders (the funneling of claims into one
12 proceeding to preserve the debtors’ estate) under certain circumstances applicable
13 to Manville I—it also looked to § 105(a) for additional support. Id. at 93; id. at 94
14 (noting both statutory and equitable powers to dispose of the debtor’s property
15 free from third-party interests). Moreover, the releases there were “essential” to a
16 “workable reorganization.” Id. at 94. Thus, although Manville I was in the asbestos
17 context, its premise that this Circuit permits third-party releases in bankruptcy still
18 stands. See In re Metromedia Fiber Network, Inc. (“Metromedia”), 416 F.3d 136, 142
58 1 (2d Cir. 2005) (citing Manville I); Drexel, 960 F.2d at 293 (recognizing the propriety
2 of third-party releases in a reorganization).
3 Appellees argue, however, that it is significant that Manville I, unlike the
4 current appeal, concerned asbestos products because the Bankruptcy Code now
5 explicitly authorizes releases in such circumstances. Trustee Br. at 41–42. That is
6 because in 1994 Congress enacted 11 U.S.C. § 524(g), which expressly allows for
7 the injunction of third-party claims against non-debtors in “actions seeking
8 recovery for damages allegedly caused by the presence of, or exposure to, asbestos
9 or asbestos-containing products.” 11 U.S.C. § 524(g)(2)(B)(i)(I); see Bankruptcy
10 Reform Act of 1994, Pub. L. No. 103-394, 108 Stat. 4106 (1994). Thus, under
11 Appellees’ view, “[h]ad Congress intended to allow bankruptcy courts to adjust
12 the relationship between non-debtors and other non-debtors in this manner, it
13 would have said so expressly—as it did when it authorized narrow non-debtor
14 releases in the context of bankruptcies involving asbestos.” Trustee Br. at 3.
15 The first blow to Appellees’ restrictive reading of the statute comes from the
16 text of the Bankruptcy Reform Act of 1994 itself, which states:
17 RULE OF CONSTRUCTION.—Nothing in [the language since 18 enacted as § 524(g)], shall be construed to modify, impair, or 19 supersede any other authority the court has to issue injunctions in 20 connection with an order confirming a plan of reorganization.
59 1 2 Pub. L. 103-394, § 111(b), 108 Stat. 4106, 4117 (1994). Thus, in enacting § 524(g),
3 Congress expressly intended not to change the pre-existing powers of bankruptcy
4 courts. Therefore, neither Manville I nor the subsequent adoption of § 524(g)
5 supports a limitation of its reasoning to asbestos claims.
6 More importantly, this Court’s opinion in Metromedia flatly rejects a
7 restrictive interpretation of the Bankruptcy Code by stating that third-party
8 releases can be valid outside of the asbestos context. 416 F.3d at 141. In that case,
9 the debtor Metromedia’s reorganization plan allowed certain non-debtor directors
10 and officers of the company to “receive a full and complete release, waiver and
11 discharge from . . . any holder of a claim of any nature . . . arising out of or in
12 connection with any matter related to” Metromedia or its subsidiaries. Id. at 141
13 (alterations in original). Creditors challenged the imposition of these types of
14 releases generally on statutory grounds, and specifically on equitable grounds.
15 Although this Court ultimately rejected the imposition of the releases, we did so
16 based on insufficient factual findings, not because we found that such releases
17 could not ever be approved. Id. at 143.
18 Regarding the third-party releases themselves, the Metromedia court faced
19 many of the same arguments we are presented with today. There, appellants had
60 1 primarily contended that the non-debtor releases were unauthorized by the
2 Bankruptcy Code, at least on the findings made by the bankruptcy court. Id. at
3 141. But in Metromedia, we did not accept those arguments. Instead, we noted that
4 “[w]e have previously held that ‘in bankruptcy cases, a court may enjoin a creditor
5 from suing a third party, provided the injunction plays an important part in the
6 debtor’s reorganization plan.’” Id. at 141 (alterations adopted) (quoting Drexel, 960
7 F.2d at 293); see also Metromedia, 416 F.3d at 141 (“it is clear that such a release is
8 proper only in rare cases”). And, while we acknowledged that some circuits have
9 permitted such releases only in the asbestos context, id., we focused on the
10 circumstances under which other circuits “have approved nondebtor releases,”
11 such as when: “the estate received substantial consideration,” the plan channeled
12 enjoined claims to a settlement fund as opposed to extinguishing them, “the
13 enjoined claims would indirectly impact the debtor’s reorganization” due to
14 factors like indemnification, “the plan otherwise provided for the full payment of
15 the enjoined claims,” and affected creditors consent to such releases. Id. at 142.
16 Following this review, we then articulated two requirements for the imposition of
17 such releases in this Circuit. First, in order for the inclusion of a release to be
18 approved, the release “itself” must be “important to the Plan.” Id. at 143 (emphasis
61 1 in the original). Second, the “breadth” of the release must also be “necessary to
2 the Plan.” Id.
3 Thus, while we ultimately ruled that the bankruptcy court’s findings were
4 insufficient for the imposition of releases under the facts of that case, Metromedia
5 nevertheless rests upon the premise that such releases may be permitted so long as
6 bankruptcy courts make sufficient factual findings and satisfy certain equitable
7 considerations. Id. at 143.
8 For these reasons, our precedents permit the imposition of third-party
9 releases jointly under 11 U.S.C. § 105(a) and 11 U.S.C. § 1123(b)(6).
10 D. Factors Relevant to Releasing Direct Third-Party Claims Against 11 Non-Debtors
12 Having upheld the bankruptcy court’s statutory authority and jurisdiction
13 to impose such releases, we now turn to the circumstances under which releases
14 may be approved. The Trustee appears to take issue with the fact that the Releases
15 were approved despite their failing to satisfy certain factors stated in Metromedia.
16 The Debtors, by contrast, contend that this is exactly the sort of case that
17 epitomizes when third-party nonconsensual releases are proper because (1) the
18 releases are essential to the confirmation of the Plan (including serving as its
19 primary financing); (2) litigation of the settled claims would negatively impact the
62 1 res of the Debtors’ estates; (3) the bankruptcy court already narrowed the scope of
2 the releases; and (4) this case is highly unusual and complex given the
3 “inextricable interrelation between the claims against the Debtors and against the
4 Sacklers,” Debtors Br. at 65.
5 We now clarify any ambiguity and identify the factors that should be
6 considered in order for a bankruptcy court to approve of nonconsensual third-
7 party releases of direct claims against a non-debtor and to include them in a plan.
8 In doing so, we remain conscious of the “heightened” “potential for abuse” posed
9 by such releases, and our analysis of pertinent factors is informed by that risk. 19
10 Metromedia, 416 F.3d at 140. We wholeheartedly endorse the view that “third-
11 party releases are not a merit badge that somebody gets in return for making a
12 positive contribution to a restructuring,” nor are they “a participation trophy” or
13 “gold star for doing a good job.” In re Aegean Marine Petroleum Network Inc., 599
14 B.R. 717, 726–27 (Bankr. S.D.N.Y. 2019).
19This Court has also observed that it is abusive for a bankruptcy court to enjoin third- party claims against a non-debtor based solely on the non-debtor’s financial contribution to the estate. Manville III, 517 F.3d at 66. “It is . . . precisely this conditioning of financial participation by non-debtors on releases that is subject to the sort of abuse foreseen in Metromedia.” Id. (internal quotation marks omitted). 63 1 With that said, bankruptcy courts should look to the following seven factors
2 before imposing nonconsensual third-party releases:
3 First, courts should consider whether there is an identity of interests
4 between the debtors and released third parties, including indemnification
5 relationships, “such that a suit against the non-debtor is, in essence, a suit against
6 the debtor or will deplete the assets of the estate.” Dow Corning, 280 F.3d at 658;
7 see also In re Master Mortgage Investment Fund, 168 B.R. 930, 935 (Bankr. W.D. Mo.
8 1994) (same). 20 This requirement reflects our observation in Metromedia that non-
9 debtor releases have been allowed in circumstances including those where “the
10 enjoined claims would indirectly impact the debtor’s reorganization by way of
11 indemnity or contribution.” Metromedia, 416 F.3d at 142 (internal quotation marks
12 omitted).
13 Second, courts should consider whether claims against the debtor and non-
14 debtor are factually and legally intertwined, including whether the debtors and
15 the released parties share common defenses, insurance coverage, or levels of
20The multifactor test articulated in In re Master Mortgage Investment Fund has been widely cited by courts in other circuits. See, e.g., Monarch Life Ins. Co. v. Ropes & Gray, 65 F.3d 973, 980 (1st Cir. 1995); Gillman v. Continental Airlines (In re Cont'l Airlines), 203 F.3d 203, 217 n.17 (3d Cir. 2000); In re Chicago Invs., LLC, 470 B.R. 32, 95 (Bankr. D. Mass. 2012); In re U.S. Fidelis, Inc., 481 B.R. 503, 519 (Bankr. E.D. Mo. 2012). 64 1 culpability. We note that although the bankruptcy court did not list this as a factor,
2 it discussed that releases limited to those claims legally intertwined with the
3 Debtors’ conduct are appropriately subject to settlement. Purdue I, 633 B.R. at 104.
4 We agree.
5 Third, courts should consider whether the scope of the releases is
6 appropriate. This is the second factor evaluated in Metromedia. 416 F.3d at 143. In
7 our view, a release is proper in scope when its “breadth” is “necessary to the Plan.”
8 Id.
9 Fourth, courts should consider whether the releases are essential to the
10 reorganization, in that the debtor needs the claims to be settled in order for the res
11 to be allocated, rather than because the released party is somehow manipulating
12 the process to its own advantage. In other words, it must be the case that, without
13 the releases, “there is little likelihood of [a plan’s] success.” Master Mortg. Inv.
14 Fund, 168 B.R. at 935. This factor also reflects the first factor required by
15 Metromedia—that the release be important to the plan. 416 F.3d at 143.
16 Fifth, courts should consider whether the non-debtor contributed
17 substantial assets to the reorganization. This factor was mentioned by this Court
65 1 in Metromedia, 416 F.3d at 142–43, and is emphasized in Dow Corning, 280 F.3d at
2 658, and Master Mortgage Investment Fund, 168 B.R. at 935.
3 Sixth, courts should consider whether the impacted class of creditors
4 “overwhelmingly” voted in support of the plan with the releases. Master Mortg.
5 Inv. Fund, 168 B.R. at 935. A reference point to define “overwhelmingly” can be
6 found in 11 U.S.C. § 524(g)(2)(B)(ii)(IV)(bb), which requires approval by a
7 minimum of 75% of voting creditors in favor of the plan. However, we consider
8 that threshold to be the bare minimum, and instead express approval for requiring
9 overwhelming approval of the plan.
10 Seventh, and finally, courts should consider whether the plan provides for
11 the fair payment of enjoined claims. In Metromedia, we noted that other courts
12 have found such releases permissible when “the plan . . . provided for the full
13 payment of the enjoined claims.” 416 F.3d at 142; see also Dow Corning, 280 F.3d at
14 658 (requiring that “[t]he plan provides a mechanism to pay for all, or substantially
15 all, of the class or classes affected by the injunction”). While the full payment of
16 the enjoined claims would of course tend to favor the approval of a plan containing
17 such releases, we are concerned with the fairness of the payment, as opposed to
18 the final amount of payment. Because the amount of the payment does not
66 1 necessarily indicate its fairness, the determinative question is not whether there is
2 full payment, but rather whether the contributed sum permits the fair resolution
3 of the enjoined claims.
4 Although consideration of each factor is required, it is not necessarily
5 sufficient—there may even be cases in which all factors are present, but the
6 inclusion of third-party releases in a plan of reorganization should not be
7 approved. Further, as contemplated by Dow Corning, the bankruptcy court is
8 required to support each of these factors with specific and detailed findings. 280
9 F.3d at 658. For the bankruptcy court to make such findings, extensive discovery
10 into the facts surrounding the claims against the released parties will most often
11 be required.
12 Finally, as with any term in a bankruptcy plan, a provision imposing
13 releases of claims like that at issue here must be imposed against a backdrop of
14 equity. See Energy Resources, 495 U.S. at 549 (describing the authority conferred by
15 § 1123(b)(6) as deriving from bankruptcy courts’ status as “courts of equity”); see
16 also Adelphia Bus. Sols., Inc. v. Abnos, 482 F.3d 602, 609 (2d Cir. 2007) (“Section 105(a)
17 grants broad equitable power to the bankruptcy courts to carry out the provisions
18 of the Bankruptcy Code so long as that power is exercised within the confines of
67 1 the Bankruptcy Code.”). Given the potential for abuse, courts should exercise
2 particular care when evaluating these types of releases.
3 E. Application of These Factors Based Upon the Bankruptcy Court’s 4 Findings
5 In light of these factors, we now evaluate the bankruptcy court’s findings
6 supporting its approval of the Plan. The thorough bankruptcy court opinion,
7 which indicated that it grounded its findings in the tens of millions of documents
8 produced in discovery, informs our analysis. 21
9 Factor 1. Identity of Interests Between Debtors and Released 10 Parties 11 12 We have described supra the identity of interests between the Debtors and
13 those Sacklers named as defendants in the litigations, chiefly that the named
14 Sacklers were directors and officers of the Debtors. Purdue was a closely held
15 corporation, and, according to the bankruptcy court, the record tended to show
16 that the Sacklers “took a major role in corporate decision-making, including
17 Purdue’s practices regarding its opioid products that was more akin to the role of
21The extensive discovery provided by the parties is exactly the sort that bankruptcy courts should expect when permitting broad third-party releases. 68 1 senior management.” Purdue I, 633 B.R. at 93. This overlap constitutes a sufficient
2 identity of interests between the Debtors and the Sacklers.
3 Factor 2. Factual and Legal Overlap Between Claims Against 4 Debtors and Settled Third-Party Claims 5 6 In the prior sections, we also discussed the factually and legally intertwined
7 nature of the claims against both the Debtors and the Sacklers. More importantly,
8 the bankruptcy court required that the releases only “apply where . . . a debtor’s
9 conduct or the claims asserted against it [are] a legal cause or a legally relevant
10 factor to the cause of action against the shareholder released party,” Deferred Joint
11 App’x at 1330–31, and the released claims directly affect the res, Purdue I, 633 B.R.
12 at 97–98. Cf. Metromedia, 416 F.3d at 141 (ruling that factual circumstances and
13 equitable considerations did not support a broad release that included the “waiver
14 and discharge from . . . any holder of a claim of any nature . . . of any and all claims
15 . . . arising out of or in connection with any matter related to [the Debtor] or one or
16 more subsidiaries . . . based in whole or in part upon any act or omission or
17 transaction” (alterations in original, emphasis added)). By so narrowing the
18 Releases, the bankruptcy court ensured sufficient overlap between claims against
19 the Debtors and the settled third-party claims.
69 1 Factors 3. and 4. The Releases are Essential to the 2 Reorganization & Proper in Scope 3 4 We next evaluate, in tandem with our analysis of the Releases’ scope,
5 whether the Releases are essential to reorganization. 22 See Metromedia, 416 F.3d at
6 143. The Releases are essential to reorganization for two reasons. First and
7 foremost, as described supra, the Releases are required to ensure that the valuation
8 of the res is settled. Otherwise, the Debtors would, in all likelihood, be required to
9 litigate indemnity and contribution claims brought against them by the Sacklers,
10 which would likely deplete the res, no matter the ultimate outcome of those claims.
11 The bankruptcy court limited the Releases extensively in order not to exceed its
12 jurisdiction, restricting their scope to ensure that the released claims related to the
13 Debtors’ conduct and the Estate. Second, the res itself amounted to only
14 approximately $1.8 billion. Without the Plan, the government would recover its
15 $2 billion first, thereby depleting the res completely. As a result, many victims of
16 the opioid crisis would go without any assistance and face an uphill battle of
22Although we describe these as two separate factors, following Metromedia, we analyze them together in this case because the two factors are interrelated. We nevertheless acknowledge that a case with a different factual record might require them to be considered separately. 70 1 litigation (in which a single claimant might disproportionately recover) without
2 fair distribution.
3 On the question of what is essential to the Plan, the Trustee argues that the
4 Sacklers themselves created the conditions that make these releases essential, and
5 that, as a term of their contribution, the Sacklers had insisted upon these releases
6 before the Debtors even entered bankruptcy. Per the Trustee, these facts
7 demonstrate the Sacklers’ unworthiness of receiving the benefit of the releases.
8 First, we are not called upon to determine whether the Sacklers are worthy of
9 receiving the benefit of the releases. As noted supra, the various equities of the
10 Plan were carefully considered by the bankruptcy court. However, to the extent
11 that there is a fear that this opinion could be read as a blueprint for how
12 individuals can obtain third-party releases in the face of a tsunami of litigation, we
13 caution that the key fact regarding the indemnity agreements at issue is that they
14 were entered into by the end of 2004—well before the contemplation of
15 bankruptcy. Acts taken “‘in contemplation of’ bankruptcy ha[ve] long been, and
16 continue[] to be, associated with abusive conduct.” Milavetz, Gallop & Milavetz,
17 P.A. v. United States, 559 U.S. 229, 240 (2010). We would be far less persuaded if
18 the party seeking to be released entered into this type of indemnity agreement in
71 1 contemplation of such a third-party release in bankruptcy. Of course, this similar
2 restriction falls in line with our decision in Manville I, where we approved of
3 releases in favor of insurance companies. 837 F.2d at 90. Similarly, in that action,
4 there was no suggestion that the insurance policies were taken out in
5 contemplation of bankruptcy. See id. at 90–91.
6 As our precedents have suggested, and as we make clear today, if the only
7 reason for the inclusion of a release is the non-debtor’s financial contribution to a
8 restructuring plan, then the release is not essential to the bankruptcy. See Manville
9 III, 517 F.3d at 66 (cautioning against this type of situation as abusive). But that is
10 not the present case. Here, the Releases are both needed for the distribution of the
11 res and to ensure the fair distribution of any recovery for claimants. Thus, we deem
12 the scope of the Releases—as limited by the bankruptcy court—appropriate and
13 the Releases essential to the reorganization.
14 Factor 5. Substantial Contribution to the Reorganization
15 When evaluating the substantial nature of the released parties’ contribution,
16 our primary focus is on the impact of the financial contribution. The bankruptcy
17 court found the financial contribution by the Sacklers, which totaled
18 approximately $4.325 billion, to be substantial and of course did not change its
72 1 mind when the Sacklers agreed, after the initial approval of the Plan and during
2 the pendency of this appeal, to increase their contribution to make the settlement
3 equal approximately $5.5-6.0 billion. Order Pursuant to 11 U.S.C. §§ 105 and
4 363(b) Authorizing and Approving Settlement Term Sheet, In re Purdue Pharma
5 L.P., No. 19-23649-shl (Bankr. S.D.N.Y. Mar. 10, 2022), ECF No. 4503. The
6 bankruptcy court stated its belief that this is one of the largest contributions to
7 bankruptcy anywhere in the country. Purdue I, 636 B.R. at 107; cf. In re Mallinckrodt
8 PLC, 639 B.R. 837, 852 (Bankr. D. Del. 2022) (approving of bankruptcy plan with
9 releases where the non-debtor third-party contributed $1.6 billion).
10 The Trustee primarily argues that the Plan is inequitable because it
11 improperly provides a quid pro quo to the Debtors, and that if the Sacklers had
12 declared bankruptcy, under the Bankruptcy Code they would have had to
13 dedicate substantially all of their net worth (an estimated $11 billion) to the
14 Estate—well more than the approximately $5.5-6.0 billion they have agreed at this
15 point to fund. 23 It is not for this Court to determine whether a greater contribution
16 from the Sacklers would be desirable, but rather our role is simply to decide
23At oral argument, answering a question from the Court, the Trustee conceded that it would oppose the releases even if the Sacklers contributed $10 billion. Oral Arg. Hr’g at 1:27:45–58. 73 1 whether the bankruptcy court erred in finding the Sacklers’ contribution
2 substantial. It did not. Five and a half billion dollars—purportedly the largest
3 contribution in history for such releases—is a significant sum.
4 Factor 6. Overwhelming Approval by Creditors
5 The claimants voted overwhelmingly to approve the Plan. Over 95% of the
6 personal injury classes voted to accept the plan, which is well above the 75%
7 benchmark. Moreover, with the Nine no longer pursuing their objection, the main
8 challenge to this appeal is not by creditors, but by the Trustee—a government
9 entity without a financial stake in the litigation.
10 Factor 7. Fair Payment of Enjoined Claims
11 Finally, the Plan provides for the fair payment of claims. As Appellees
12 concede, the valuation of the claims—estimated at $40 trillion—far exceeds the
13 total funds available, as well as the Sacklers’ personal wealth. The bankruptcy
14 court also acknowledged that although “in a vacuum the ultimate judgments that
15 could be achieved on the estates’ claims (and the closely related third-party claims
16 that are being settled under the plan) might well be higher than” the Sacklers’
17 contribution to the plan, “the vast size of the claims against the Debtors and the
18 vast number of claimants creates the need for the plan’s intricate settlements.”
74 1 Purdue I, 633 B.R. at 93. Thus, as it is not possible to require the full payment of all
2 claims, we do prioritize fair allocation over the full payment of any one claim. The
3 Trustee has not alleged any unequal treatment of claimants, and no party gives us
4 reason to disturb the bankruptcy court’s findings that the settlements and
5 allocations were “fair and equitable.” Purdue I, 633 B.R. at 84 (internal quotation
6 marks omitted).
7 * * *
8 For the reasons stated, the bankruptcy court’s detailed findings support
9 approval of the Plan under each of the seven factors that we announce in this
10 opinion. We would also note the additional concessions made by the Sacklers—
11 including governance requirements, abatement trusts, the public document
12 archive, and divestment of the Sacklers from the opioid business worldwide—
13 contribute to the Plan’s equity. Purdue I, 636 B.R. at 107. We therefore find no
14 error with the bankruptcy court’s weighing of the equitable considerations.
75 1 III. Due Process
2 Although the bankruptcy court found that there was adequate notice to
3 impose the releases, 24 on appeal, the Trustee asserts that the releases in this action
4 did not comply with due process. We, however, find no due process violation.
5 A procedural due process claim entails a two-part inquiry: whether
6 claimants were deprived of a protected interest and, if so, whether claimants
7 received adequate notice and a meaningful opportunity to be heard. Spinelli v.
8 City of New York, 579 F.3d 160, 168 (2d Cir. 2009). The releases extinguish causes
9 of action, which, as the parties impliedly concede, are a constitutionally protected
10 property interest. See Logan v. Zimmerman Brush Co., 455 U.S. 422, 428 (1982) (“a
11 cause of action is a species of property protected by the Fourteenth Amendment’s
12 Due Process Clause”); Rosu v. City of New York, 742 F.3d 523, 526 (2d Cir. 2014)
13 (“[T]he cause of action itself constitutes a cognizable property interest.”). Thus,
14 the only remaining question is whether claimants lacked adequate notice or a
15 meaningful opportunity to be heard. Spinelli, 579 F.3d at 168. 25
24 The district court did not reach this issue. 25 In this respect, the Trustee is correct that the Release “permanently extinguish[es]
virtually all opioid-related claims against the Sacklers and other non-debtors without the consent of every affected claimant.” Trustee Br. at 50. Certainly, that aspect of the Release raises due process concerns—but it does not resolve them. “Once due process is triggered, the question becomes what process is due.” In Matter of Motors Liquidation Co., 76 1 The Trustee argues that there was a denial of due process because the
2 bankruptcy court failed to provide adequate notice of the confirmation hearing
3 and because the language of the Release is dense. “Due process requires notice
4 reasonably calculated . . . to apprise interested parties of the pendency of the
5 action.” Burda Media, Inc. v. Viertel, 417 F.3d 292, 303 (2d Cir. 2005) (alteration in
6 original, internal quotation marks omitted). “There is no rigid formula as to the
7 kind of notice that must be given; notice required will vary with circumstances
8 and conditions.” Baker v. Latham Sparrowbush Assocs., 72 F.3d 246, 254 (2d Cir. 1995)
9 (internal quotation marks omitted). Here, the bankruptcy court made detailed
10 findings that notice of the confirmation hearing was widespread through a variety
11 of media and that direct notice was provided to any creditors of the Debtors
12 (potential claimants here). The bankruptcy court further observed that although
13 legal training may have been helpful to understanding the initial wording of the
14 releases, the narrowed releases were written more clearly and in “simple . . . plain
15 English.” Purdue I, 633 B.R. at 60. The Trustee has given no reason to consider
16 such findings error. See also Mallinckrodt, 639 B.R. at 876–77 (rejecting similar
17 arguments by the Trustee because of the extensive notice, the representation of the
829 F.3d 135, 158 (2d Cir. 2016). The Trustee’s focus on the effect of the Release only gets it so far. 77 1 victims by a UCC, the lack of a deadline on claims that can access the opioid trusts,
2 and the fact that the court considered those who might not have received or
3 understood notice). Moreover, the bankruptcy court gave process—i.e.,
4 meaningful opportunity to be heard—at the confirmation hearing, which lasted
5 for six days.
6 The Trustee also questions whether such a release, without an ability to opt-
7 out, can comply with due process because it effectively denies claimants their day
8 in court. But, again, the Due Process Clause does not absolutely protect against
9 the deprivation of property; it instead ensures that a deprivation does not occur
10 without due process. In bankruptcy, the sufficiency of process turns on the
11 adequacy of notice and a meaningful opportunity to be heard, both of which, as
12 explained above, occurred here. 26 The Trustee’s argument would essentially call
13 into question all releases through bankruptcy, including bankruptcy discharges
14 (which are one of the most important features of bankruptcy). We decline to so
15 undermine such a critical component of bankruptcy. As described supra, the
16 bankruptcy court here acted within its jurisdiction over the bankruptcy estate—
26Whatever other constitutional concerns might be raised by the extinguishing of state law claims in bankruptcy, the parties have not argued them here.
78 1 even if the third-party claims were not actually the property of the estate—and
2 therefore did not violate due process.
3 * * *
4 In sum, we reverse the district court’s holding that the bankruptcy court
5 lacked the authority to approve the Plan that included the nonconsensual third-
6 party releases. We instead hold that the bankruptcy court properly approved the
7 Plan and made the requisite detailed factual findings to approve of the
8 Shareholder Releases.
9 IV. The Canadian Creditors’ Foreign Sovereign Immunity Act Claim
10 The Canadian Creditors raise various arguments based upon their
11 contention that Section 10.7(b) of the Plan imposes liability personal to the
12 Canadian Creditors in a manner that violates their sovereign immunity.
13 As a threshold matter, it is not clear that sovereign immunity is even
14 implicated by the releases. To the contrary, at least in the context of discharging
15 claims against a debtor, “[a] debtor does not seek monetary damages or any
16 affirmative relief from a State by seeking to discharge a debt; nor does he subject
17 an unwilling State to a coercive judicial process. He seeks only a discharge of his
18 debts.” Tenn. Student Assistance Corp. v. Hood, 541 U.S. 440, 450 (2004). The releases
79 1 here do not require a suit to be maintained against the Canadian Creditors. Nor
2 do they seek to impose personal liability on the Canadian Creditors. The Canadian
3 Creditors also cannot be described as unwilling with regard to this judicial
4 process, in which they have fully and voluntarily participated. S.G. Phillips
5 Constructors, Inc. v. City of Burlington (In re S.G. Phillips Constructors, Inc.), 45 F.3d
6 702, 707 (2d Cir. 1995) (“The Supreme Court and this court have consistently held
7 that in filing a proof of claim the petitioner submits to the bankruptcy court’s
8 equitable jurisdiction.”). Moreover, the Foreign Sovereign Immunities Act also
9 does not protect the Canadian municipalities because 28 U.S.C. § 1605(a)(1)
10 provides that a foreign state will not be immune from jurisdiction of the courts
11 where the foreign state has waived its immunity either explicitly or by implication.
12 For these reasons, we find that the Plan does not violate the sovereign immunity
13 of the Canadian Creditors.
14 V. The Cross-Appeal
15 The bankruptcy court and the district court both determined that the Plan
16 properly differentiated the Canadian objectors’ claims from their domestic
17 counterparts. The Canadian Creditors contend it is inequitable that they do not
18 have access to the abatement trusts, but domestic creditors do. Thus, in their view,
80 1 because § 1129(a)(1) requires equal treatment, the Plan fails. We do not find those
2 arguments persuasive and affirm the district court.
3 Section 1123(a)(1) provides that “[n]otwithstanding any otherwise
4 applicable non-bankruptcy law, a plan shall designate, subject to section 1122 of
5 this title, classes of claims.” 11 U.S.C. § 1123(a)(1). Under 11 U.S.C. § 1122(a), plans
6 may classify claims in a particular class so long as those claims are “substantially
7 similar to the other claims or interests of such class.” Yet, the statute itself “does
8 not explicitly address whether similar claims must be placed in the same class.”
9 Boston Post Rd. Ltd. P’Ship v. FDIC (In re Boston Post Rd. Ltd. P’ship), 21 F.3d 477, 481
10 (2d Cir. 1994). Looking to other circuits, which “have generally held that separate
11 classification of similar claims is permissible only upon proof of a legitimate
12 reason for separate classification, and that separate classification to gerrymander
13 an affirmative vote is impermissible,” id., this Court has held that “similar claims
14 may not be separately classified solely to engineer an assenting impaired class,”
15 id. at 482. Instead, the separation of similar claims can only be justified by a
16 legitimate reason. Id. at 483; see also In re W.R. Grace & Co., 729 F.3d 311, 329 (3d
17 Cir. 2013) (ruling that the separate classification of Canadian claims is appropriate
18 because the “Canadian and U.S. property damage claimants . . . operate under
81 1 separate tort regimes[] and reached separate settlement agreements”); Dow
2 Corning, 280 F.3d at 662 (approving the separate classification of foreign claims
3 because “the bankruptcy court determined that the evidence supported the factual
4 assumptions upon which the classifications are based,” including clear expert
5 witness testimony about tort recovery in other nations). Here, both the bankruptcy
6 court and the district court found that the claims were properly differentiated in
7 the Plan because the claims are subject to different regulatory regimes that result
8 in different types of recovery and the Canadian creditors did not participate in the
9 mediation allocation. Purdue I, 633 B.R. at 70; Purdue II, 635 B.R. at 117.
10 The Cross-Appellants argue regulatory differences do not suffice to account
11 for the different classification. However, we see no reason to disturb the
12 conclusions of the bankruptcy court and the district court. There are substantive
13 differences among the claims, including both the types of claims and elements of
14 causes of action. Moreover, the Canadian objectors have another source of
15 recovery: Purdue Canada. 27 We believe those reasons alone provide enough
27Of note, Purdue Canada reached a separate settlement of $150 million. See Settlement reached with Purdue Pharma (Canada) for opioid damages, British Columbia Government News (June 29, 2022), https://news.gov.bc.ca/releases/2022AG0044-001031. 82 1 support to differentiate the claims, and thus to affirm the district court’s holding
2 on the cross-appeal.
3 CONCLUSION
4 For the reasons set forth above, we REVERSE the district court’s order
5 holding that the Bankruptcy Code does not permit nonconsensual third-party
6 releases of direct claims, and AFFIRM the bankruptcy court’s approval of the Plan,
7 including the modification made on March 10, 2022, and the case is REMANDED
8 to the district court for such further proceedings as may be required, consistent
9 with this opinion. We also AFFIRM the district court’s denial of the Canadian
10 Creditors’ cross-appeal.
83 RICHARD C. WESLEY, Circuit Judge, concurring in the judgment:
Does a bankruptcy court have the power to release direct or particularized
claims asserted by third parties against nondebtors without the third parties’
consent? Yes—this Court said so in In re Drexel Burnham Lambert Grp., Inc., 960
F.2d 285, 293 (2d Cir. 1992). Drexel has not been overruled either by the Supreme
Court or by this Court sitting en banc. It is binding. Consequently, although the
parties have sacrificed a forest on the matter—and rightly so, weighty as it is—that
ship has, for better or worse, sailed. I therefore reluctantly concur with the
majority’s conclusion that a bankruptcy court has the authority to approve a
Chapter 11 reorganization plan that includes nonconsensual nondebtor releases.
Again: Drexel says so.
That said, neither Drexel, nor our subsequent discussion of nonconsensual
nondebtor releases in Metromedia, traces that power back to any provision of the
Bankruptcy Code. See In re Metromedia Fiber Network, Inc., 416 F.3d 136, 142
(2d Cir. 2005). In fact, although Metromedia acknowledged that Drexel had already
crossed the bridge, it also appreciated its questionable structure, and was wary to
traverse it once more. To the point, Judge Jacobs carefully explained “the
reluctance to approve nondebtor releases,” and cautioned that nowhere—apart
1 from asbestos-related bankruptcies—does the Code authorize them. See id. The
majority concedes as much; it recognizes that “whatever equitable powers remain
in the bankruptcy courts must and can only be exercised within the confines of the
Bankruptcy Code.” Law v. Siegel, 571 U.S. 415, 421 (2014). Today, it fills that gap
with §§ 105 and 1123(b)(6).
Those provisions of the Bankruptcy Code say nothing about nondebtor
releases, and I am not convinced that statutory footing is up to the task.
Accordingly, although mindful that, for this Court, the issue has already been
settled (albeit without any basis in the Code), I write separately to highlight my
concerns.
Those concerns are, in brief: extinguishing direct, particularized claims
against nondebtors without the claimholder’s consent, and without compensating
the claimholder, is an extraordinarily powerful tool for a bankruptcy court to
wield—indeed, for any court to wield. Congress once before provided clarity on
the propriety of third-party releases in bankruptcy. It could do so again, but, since
1994, has not. Absent any movement on that front, the question, which has
divided the courts of appeals for decades, would benefit from nationwide
2 resolution by the Supreme Court. In that event, a uniform view of the problem
would emerge.
I
The majority’s overview of the facts, procedural history, and opinions
below, is thorough and well stated. For present purposes, it is sufficient to
emphasize exactly what the Shareholder Release 1 purports to do.
Prior to Purdue’s Chapter 11 filing, widespread efforts to hold Purdue
legally accountable for its role in the opioid epidemic eventually revealed, at least
in the eyes of countless plaintiffs, that certain members of the Sackler family were
heavily involved with unlawful efforts to boost Purdue’s opioid sales. See In re
Purdue Pharma, L.P. (“Purdue II”), 635 B.R. 26, 50–51 (S.D.N.Y. 2021). Seeking to
hold the Sackler family members directly liable for their part in perpetuating the
opioid epidemic, both private litigants as well as state Attorneys General turned
to various state statutes, including consumer protection laws, which,
notwithstanding considerable factual overlap with allegations of corporate
liability, impose a separate and independent duty on individuals who, by virtue
1 Defined terms here coincide with the those in the majority opinion.
3 of their role as either officer, manager, or director of a corporation, personally
participated in corporate wrongdoing. See id. As Judge McMahon aptly put it:
[I]t is undisputed that these laws impose liability, and even penalties, on such persons independent of any corporate liability (or lack of same), and independent of any claim the corporation could assert against them for faithless service as a result of those same acts.
Id. at 91. These claims “arise out of the Sacklers’ own conduct.” Id.
The Shareholder Release forever halts those proceedings in their tracks. It
permanently enjoins the private and state litigants, as well as all future plaintiffs,
from pursuing those claims against the Sacklers—indeed, any claim “of any kind,
character[,] or nature whatsoever, Special App’x 798—so long as the Debtors’
“conduct, omission, or liability” is “the legal cause or is otherwise a legally
relevant factor.” 2 Id. at 920. No carveout exists for claims based on fraud—claims
2The limiting effect of the “legally relevant” requirement is elusive, and its precise reach has, understandably, not been articulated either by the parties, the bankruptcy court, or the majority. Their failure to do so is no fault of their own; it is difficult to predict the various claims which might be asserted directly against the Sacklers, and future litigation will determine whether any given claim falls within the provision. Still, one can envision an exceedingly broad understanding of “legal relevance,” and I, for one, am skeptical of the requirement’s limiting effect. To illustrate, at issue in Manville III were direct claims against Manville’s primary insurer alleging that the insurer violated purported state-imposed duties to disclose certain asbestos-related information it learned from Manville. See In re Johns-Manville Corp. (“Manville III”), 517 F.3d 52, 66 (2d Cir. 2008) rev'd and remanded on other grounds sub nom. Travelers Indem. Co. v. Bailey, 557 U.S. 137 (2009). We held that notwithstanding the factual overlap of those claims with claims which might be asserted against Manville, or by Manville against the insurer, the bankruptcy
4 from which a debtor could not seek a discharge under the Code. See 11 U.S.C.
§ 523(a)(2)(A); see also Archer v. Warner, 538 U.S. 314, 321 (2003) (“[The Code]
ensure[s] that all debts arising out of fraud are excepted from discharge no matter
their form.” (quotation omitted)). Appellants seek a release broader than that
which Congress decided was wise to make available to a debtor in bankruptcy.
On top of that, the Release does not “channel[]” the enjoined claims “to a
settlement fund” for compensation, Metromedia, 416 F.3d at 142, but instead
mandates that any value paid to personal injury claimants regarding, for example,
the opioid-related death of another person, be based only upon claims “held
against the Debtors, and not to any associated . . . Channeled Claim against a
non-Debtor party.” Special App’x 634, 693, 734–35. In other words, the value of a
channeled claim is only the value of claims against the estate. 3
court was without jurisdiction to release the direct claims against the insurer. See id. As to those direct claims, Manville’s “conduct” or “omission” might be described as legally relevant: they were based on what the insurer learned from Manville. I am concerned that “legal relevance” might release claims mirroring those which we have previously held did not fall within bankruptcy jurisdiction.
3 Consider this example. Someone has a claim against only Purdue and it’s worth $100,000. They file a proof of claim and receive a check for some percentage of that claim. Another person has the same claim for the same amount, and a direct claim against the Sacklers worth another $100,000. Under the Plan, that party receives only the same amount as the first claimant; they receive no payout on their direct claim against the Sacklers, even though the Sacklers are released from that claim.
5 This aspect of the Release substantially broadens its reach as compared with
the release approved in Manville I. See MacArthur Co. v. Johns-Manville Corp.
(“Manville I”), 837 F.2d 89 (2d Cir. 1988). There, we rejected the notion that a
release constituted a bankruptcy discharge because the released claims were not
extinguished, but were “channeled away from the insurers and redirected at the
proceeds of the settlement.” Id. at 91. Here, the Plan expressly disallows value
being paid based on claims against nondebtors, that is, the Sacklers.4 Manville I
therefore does not lay the groundwork for the Release’s approval.
Finally, the Release is non-consensual; it binds consenting and objecting
parties, without providing an opt-out option to those who object.
In summary, the Release enjoins a broader swath of claims than a debtor
himself could seek to discharge under the Bankruptcy Code, and it does so without
providing any compensation to the claimholders, who must abide by its terms
whether they like it or not. The Release encompasses a potentially wide range of
4 Appellants dispute that characterization; they point to the Plan’s language that any distribution “is deemed to be a distribution in satisfaction of all [personal injury] Channeled Claims,” and argue that payments from the personal injury trust is in satisfaction of claims both against the Debtors and Sacklers. Mortimer Side Br. at 49 (quoting Special App’x 693). Yet simply stating as much does not make it so where, as here, the amount of distribution is based only upon claims as against the Debtors.
6 claims and cloaks the Sacklers with blanket immunity. It is “in effect . . . a []
discharge.” Metromedia, 416 F.3d at 142.
In exchange, the Sacklers have agreed, under the Plan, to offer a substantial
sum of money to the Debtors’ estate. 5 No doubt, those funds help make possible
(a) a more meaningful distribution of the Debtors’ estate to its creditors and
(b) recovery for those who hold claims against the Debtors. It is equally apparent
that the Sacklers mean what they’ve said: no release, no money. However, our
task today is not to decide whether, as a policy matter, the Release is justified.
Instead, without ignoring that the Sacklers’ substantial contribution will likely
play a meaningful role in providing some measure of finality to the countless
families who have suffered as a result of the opioid crisis, the dispositive question
is whether, under the Bankruptcy Code, a bankruptcy court is authorized to
approve the Release. 6
5 Again, however, their contribution is not directed at the satisfaction of third parties’ direct claims against them in their individual capacity, but, instead, at the satisfaction of either claims against the Debtors, or claims held by the estate against the Sacklers. As to the latter set of claims, the Sacklers have, in essence, settled derivative claims belonging to the estate and, in return, received a release not just from those derivative claims, but also from claims independently held by third parties.
6Of course, the majority correctly recognizes that the antecedent question to the statutory authority analysis is whether the bankruptcy court had jurisdiction under the Code to approve the Release. I do not dispute its conclusion that it did; it is settled law in this
7 II
The Bankruptcy Code is silent on the matter. That is no surprise.
Bankruptcy is the “subject of the relations between a[] . . . debtor[] and his
creditors, extending to his and their relief.” Wright v. Union Cent. Life Ins. Co., 304
U.S. 502, 513–14 (1938). To that end, Congress created a “comprehensive federal
system . . . to govern the orderly conduct of debtors’ affairs and creditors’ rights.”
Eastern Equip. & Servs. Corp. v. Factory Point Nat’l Bank, 236 F.3d 117, 120 (2d Cir.
2001). In short, the Bankruptcy Code’s central focus is on the adjustment of the
debtor-creditor relationship. Of course, that adjustment can implicate the interests
Circuit that a bankruptcy court has broad “related to” jurisdiction over any civil proceedings that “might have any conceivable effect” on the estate. See SPV OSUS Ltd. v. UBS AG, 882 F.3d 333, 339–40 (2d Cir. 2018). In the easy case, that effect can be direct, as it was in Manville I. There, the claims asserted against the insurer sought recovery from the res itself. See Manville I, 837 F.2d at 93. The bankruptcy court had jurisdiction to prevent the third party from “collect[ing] out of the proceeds of Manville’s insurance policies….” Id. In the harder case, the effect is less direct. In SPV, for example, the plaintiffs asserted direct claims against, among other defendants, UBS AG, alleging principally that UBS had aided and abetted the infamous fraud perpetrated by the debtor, Bernard L. Madoff Investment Securities LLC. See SPV, 992 F.3d at 338. Although the plaintiffs sought recovery from UBS itself, UBS, in turn, had viable claims for indemnification and contribution against the debtor. See id. at 340–42. The possibility that those claims might succeed—and the fact that the debtor would incur expense in litigating such claims—was enough to confer jurisdiction on the bankruptcy court to enjoin the plaintiff’s direct claims against UBS. See id. at 341–42. This case looks more like SPV, and the majority’s explanation as to how the direct claims against the Sacklers might affect the Debtors’ estate is sound.
8 of third-party nondebtors. 7 But as to their own independent obligations,
third-party nondebtors are, simply, a nonconcern.
Against that backdrop, there is little to glean from Congressional silence
where, as Judge McMahon put it, “one would not expect Congress to speak.”
Purdue II, 635 B.R. at 110. Appellants ask us to accept the remarkable premise that
Congress, while believing it wise to except certain claims (i.e., claims for fraud)
from a debtor’s discharge, took no issue with the idea that such claims could be
effectively discharged for nondebtors, who might contribute funds to settle claims
against the debtor, but who would face no consequences from their own,
independent liability—even though state laws mandate otherwise. Not only that,
appellants ask us to ground this grant of authority in congressional silence, as,
again, the Bankruptcy Code does not expressly authorize the practice.
And yet that silence is, effectively, what the majority sees as granting the
bankruptcy court a power that is nothing short of extraordinary. It points to
11 U.S.C. § 1123(b)(6), which it says encompasses a bankruptcy court’s residual
7For example, the automatic stay triggered by a debtor’s bankruptcy filing can apply to nondebtors in certain circumstances. See, e.g., Queenie, Ltd. v. Nygard Int'l, 321 F.3d 282, 287 (2d Cir. 2003).
9 equitable authority, and empowers a bankruptcy court to do all but that which the
Code expressly forbids. Maj. Op. at 52–53. 8
To be sure, the Court in Energy Resources characterized § 1123(b)(6) as
Congress’s recognition of a bankruptcy court’s residual equitable authority. But
it did so in connection with its observation that “bankruptcy courts, as courts of
equity, have broad authority to modify creditor-debtor relationships.” United States
v. Energy Resources Co., Inc., 495 U.S. 545, 549 (1990) (emphasis added). That case
concerned whether a debtor’s tax liabilities could be satisfied in an order as
determined by the bankruptcy court, over the objection of the Internal Revenue
Service. Nothing in Energy Resources suggests that within § 1123(b)(6)’s equitable
repository is the power to extinguish an individual’s claims against a nondebtor
without their consent, and without providing them any value in return. Indeed,
that case says nothing about a nondebtor’s obligations under the Bankruptcy Code
whatsoever.
8 The majority recognizes that the Release cannot be justified solely by § 105. See Metromedia, 416 F.3d at 142 (“Any power that a judge enjoys under § 105 must derive ultimately from some other provision of the Bankruptcy Code.” (internal citation omitted)). In other words, the Release turns on § 1123(b)(6). I focus my analysis there.
10 Instead, Energy Resources reminds us that bankruptcy courts are courts of
equity, and that their ability to carry out the Code’s provisions must be understood
with that principle in mind. But it does not answer whether under that umbrella
of equitable authority exists the power to release, on a nonconsensual basis,
nondebtors from direct claims held by third parties. Nor does Energy Resources
suggest that a bankruptcy court’s well of residual equitable authority, so long as it
does not run up against a more specific provision of the Code, is bottomless.
Again: that case concerned the adjustment of a creditor-debtor relationship,
which, as provided above, is a bankruptcy court’s raison d’etre. Courts should
understand any congressional grant of equitable authority to the bankruptcy court
with that principal purpose in mind. Releasing nondebtors from their own
liability—provided for under state law—over the objection of a claimholder and
without compensating that claimholder is so far afield from that purpose that
plugging-and-playing Energy Resources’ description of § 1123(b)(6) can’t be right.9
9 The decisions from our sister circuits cited by the majority are no more persuasive. Those decisions also rely on Energy Resources’ characterization of § 1123(b)(6). See, e.g., In re Airadigm Commc’ns, Inc., 519 F.3d 640, 657 (7th Cir. 2008). In any event, in Airadigm itself, the release did not cover, as the Release here does, claims for willful misconduct, a fact emphasized by the Seventh Circuit as justifying its confirmation. See id. That case does not signal a green light to the approval of the Shareholder Release. Neither does In re Dow Corning Corp., 280 F.3d 648 (6th Cir. 2002). There, the Sixth Circuit rejected the
11 Moreover, the Court has, in other contexts, explained that a bankruptcy
court’s equitable authority is not “unlimited,” but instead incorporates
“traditional standards in equity practice,” and that courts can look to “cases
outside the bankruptcy context” to help understand the limits of that authority.
Taggart v. Lorenzen, 139 S. Ct. 1795, 1801–02 (2019). 10 The majority does not liken
the equitable authority recognized today to anything traditionally recognized at
equity. I too am at a loss. Indeed, the idea that bankruptcy courts can order the
involuntary release of direct claims against nondebtors is “an extraordinary thing”
that is “different . . . from what courts ordinarily do.” In re Aegean Marine Petroleum
Network Inc., 599 B.R. 717, 723 (S.D.N.Y. 2019).
At bottom, if Congress intended so extraordinary a grant of authority, it
should say so. See Czyzewski v. Jevic Holding Corp., 580 U.S. 451, 465 (2017)
(requiring “more than simple statutory silence if, and when, Congress were to
third-party release because it did not provide an opportunity for objecting claimholders to recover in full. See id. at 659–61.
10 In Taggart, the Court drew on traditional equitable standards for civil contempt sanctions outside the bankruptcy context to define a bankruptcy court’s authority to hold a party in civil contempt for violating § 523(a)(2)’s discharge injunction. If, as the majority and appellants would have us believe, a bankruptcy court’s ability to enforce its injunction were limited only by that which the Code did not forbid, then Taggart’s invocation of traditional civil contempt standards would seem misplaced.
12 intend a major departure” from the Code). It has before; in 1994, it amended the
Bankruptcy Code to provide express authorization for nondebtor releases in
asbestos-related bankruptcies, subject to a stringent set of requirements. See
11 U.S.C. 524(g). 11 That amendment occurred when, at that time, courts, such as
in Drexel, were then approving nondebtor releases in non-asbestos bankruptcies.
Yet Congress endorsed nondebtor releases in only the asbestos context. The
parties debate whether Congress’ express but limited approval in § 524(g) was an
implicit rejection of nondebtor releases in non-asbestos contexts. The majority
says no. Regardless of the right answer, the majority’s answer pins this Circuit
firmly on one side of a weighty issue that, for too long, has split the courts of
appeals.
This difference in views has consequences. As it stands, a nondebtor’s
ability to be released through bankruptcy turns on where a debtor files.
Forum-dependent results are anathema to the establishment of “uniform Laws on
the subject of Bankruptcies throughout the United States.“ U.S. Const. art. I, § 8,
11 Even there, however, the injunction may extend to nondebtors only where the nondebtor is “directly liable or indirectly liable for the conduct of, claims against, or demands on the debtor….” 11 U.S.C. § 524(g)(4)(A)(ii). The Release here is broader; it covers claims aimed at the Sacklers’ liability even if it is independent from the Debtors’ liability. Even under § 524(g), it’s far from clear the Release would survive.
13 cl. 4. Finding implicit grants of extraordinary powers in congressional silence is at
cross purposes with the Code’s “comprehensive scheme.” RadLAX Gateway Hotel,
LLC v. Amalgamated Bank, 566 U.S. 639, 645 (2012). Absent direction from
Congress—and, since 1994, there has been none—or the High Court, the answer is
a function of geography.
Related
Cite This Page — Counsel Stack
In Re: Purdue Pharma L.P., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-purdue-pharma-lp-ca2-2023.